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ABSTRACT 
 
High doses of radiation (HDR) are clearly detrimental to human health, but relatively little 
is known about the health consequences following exposure to low doses of radiation (LDR, 
<10cGy). Understanding the risks associated with LDR is of great importance to the general 
public due to the recent dramatic increase in diagnostic radiological imaging. While HDR clearly 
suppress immune function, there is evidence that LDR can be immunostimulatory. Within the 
organism, defining the consequences of LDR is further complicated by the impact of genetic 
background, particularly in systems such as the immune system for which both radiosensitivity 
and genetic effects are profound. 
We addressed the issue of genetic susceptibility to LDR using the immune system as a 
target system and treated the LDR response as a complex trait analyzed using a systems 
genetics framework. Using the BXD recombinant inbred strain mouse panel as a genetic 
reference population allowed us to address the radiation response within the context of natural 
genetic variation. Our overarching hypothesis is that, within a population, the immunological 
effects of LDR exposure depend in part on the individual‟s baseline immunoprofile and gene 
expression which are ultimately dependent upon genetic background. We began by establishing 
the immunophenotypic variation (i.e., T:B cell ratio, CD4:CD8 ratio) within the BXD panel and 
used baseline spleen transcriptome profiling to identify putative candidate genes controlling 
these traits, specifically Acp1 and Ptprk for CD4:CD8 ratio. The same set of BXD strains was 
exposed to LDR (10cGy gamma radiation) to determine effects on immune function and 
oxidative stress. LDR significantly enhanced neutrophil phagocytosis in a manner that was 
independent of genetic background. In contrast, genetic background significantly impacted LDR-
induced changes in spleen superoxide dismutase activity.  
vi 
 
By integrating these results with our previous analyses of BXD RI strains, we have 
demonstrated that baseline expression of Sod2 correlates with LDR-induced SOD activity, and 
baseline CD4:CD8 ratio is inversely correlated with LDR-induced neutrophil phagocytosis. In 
addition, spleen transcriptomic data from the BXD parental strains further highlighted the impact 
of genetic background on LDR responses. These data provide the groundwork for predicting 
LDR responses using baseline expression, immunophenotypes, and/or genotype.  
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CHAPTER I 
GENERAL EXPERIMENTAL DESIGN  
 
Our goal is to identify networks of genes which underlie basic immune phenotypes, 
determine the effect of low dose radiation (LDR, 10cGy) on immune function, and characterize 
how genetic background impacts immune function and causes differential susceptibility to LDR. 
The ultimate purpose is to identify genomic regions that mediate response to LDR and 
eventually be able to predict an individual‟s susceptibility to LDR based on their genotype at 
those loci.  
The LDR response is viewed as a complex trait which is analyzed using a systems 
genetics framework. Systems genetics is both an analytical framework through which to 
assemble gene-phenotype networks and a means to uncover genetic polymorphisms that cause 
variation in these networks and lead to variable disease susceptibility. The use of a genetic 
reference population, the BXD recombinant inbred (RI) strain panel, allows us to address the 
radiation response within the context of natural genetic variation. This RI panel provides a 
population-based, genetically characterized model system in which the parental strains 
(C57BL/6J and DBA/2J) exhibit known differential responses to low dose exposure as well as 
divergent sensitivity to radiation carcinogenesis. 
This research involves the first two steps in a larger research program designed to 
create a comprehensive understanding of the molecular pathways and expression networks 
which underlie radiation-response phenotypes and how genetic variation alters these networks 
to result in altered sensitivity to LDR.  
We began by assessing the baseline immunophenotypic variation and spleen 
expression networks in the BXD panel and identified genetic loci responsible for the variation 
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(Part 1). Immunophenotyping was performed on the peripheral blood of mice from 41 BXD 
strains. The lymphocyte subpopulations analyzed included total T cells (CD3+), B cells (CD79+), 
CD4+ T cells, and CD8+ T cells. MHCII expression on lymphocytes was also analyzed. Baseline 
spleen expression analysis was performed on 38 BXD strains (Fig. 1-1) and identified 
expression networks and candidate genes underling the immunophenotypes.  
In the second phase (Part 2), we exposed BXD mice to LDR and assessed neutrophil 
function (e.g., phagocytosis and oxidative burst) and spleen anti-oxidant status (e.g., superoxide 
dismutase activity and glutathione levels) 48 hours after radiation exposure (Fig. 1-2). 
Radiation-induced spleen expression changes were measured in the parental strains (C57BL/6J 
and DBA/2J) 24 hours after exposure to high dose (1Gy) or low dose (10cGy) radiation in order 
to assess differential sensitivity to low dose radiation at the molecular level. The data from Parts 
1 & 2 were then integrated together using graph algorithms and statistical testing to identify 
correlations between baseline immunophenotype and expression and LDR responses within the 
population (Fig. 1-2). 
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Figure 1-1. Experimental design: data collection. Part 1 included baseline immunophenotyping in the peripheral 
blood of 41 BXD strains and baseline spleen expression profiling in 38 strains. Part 2 involved analysis of BXD 
responses to LDR (10cGy γ-radiation) 48 hours after irradiation, including neutrophil function (34 strains) and spleen 
biochemical assays (39 strains). Spleen expression profiling was performed on the BXD parental strains (C57BL6J 
and DBA/2J) 24 hours after LDR. 
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Figure 1-2. Experimental design: data integration. The data collected from Parts 1 & 2 were 
integrated together along with genotype information to perform quantitative trait loci mapping 
(QTL) of the baseline immunophenotype and LDR responses as well as to identify inter-
correlated traits. 
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CHAPTER II 
LITERATURE REVIEW 
General radiation biology 
Radiation biology overview 
Almost twenty years after the initial discovery of x-rays by Wilhelm Conrad Röntgen in 
1895, the Drosophila geneticist Herman Müller demonstrated that ionizing radiation causes 
mutations in living organisms (185). In the 80 years since that discovery, the biological and 
genetic consequences of exposure to ionizing radiation (IR) have been investigated.  
In order to understand the biological effects of radiation exposure, a basic understanding 
of radiation is needed. Ionizing radiation, which consists of subatomic particles (i.e., alpha 
particles, beta particles, neutrons) or electromagnetic waves (e.g., x-rays, γ-radiation, ultraviolet 
radiation), contain enough energy to displace electrons and break chemical bonds. Here, we 
primarily focus on the biological effects from x-ray and γ-radiation, both of which are 
characterized as low linear energy transfer (low-LET) radiation. In contrast to high-LET 
radiations, low-LET radiations produce ionizations only sparsely along their tract, resulting in a 
more homogenous ionization within the cell. Because high-LET radiation deposits a larger 
amount of energy per distance traveled, it induces more cellular and molecular damage per 
dose than low-LET radiation.  
The International Commission on Radiation Units and Measurements (107) defines 
radiation exposure units. The unit of absorbed radiation dose is the gray (Gy), defined as the 
energy absorbed per unit of mass. One Gy of ionizing radiation delivers 1 joule of energy per 
kilogram of matter (J/kg). Radiation dose is also commonly expressed as an “effective dose”, 
which is used to reflect the biological effects of radiation, e.g., high-LET radiation induces more 
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biological damage per Gy than low-LET radiation. Effective dose (measured in sieverts, Sv) 
equals the absorbed dose (in Gy) times the radiation weighting factor (Q) of the radiation type. 
For low-LET radiation, including x-rays and γ-radiation, Q = 1 so the absorbed dose equals the 
effective dose, or 1Gy = 1Sv. 
The study of the health consequences of IR increased dramatically following the 
devastating effects of the atomic bombs which were detonated on Hiroshima and Nagasaki, 
Japan in 1945. The first studies focused on the immediate health detriments following acute 
exposure (23, 61). Additional data for the health consequences of high doses of radiation came 
from documenting the health of firefighters that first responded to the Chernobyl Nuclear Power 
Plant event in 1986 (168).  
Simply stated, the detrimental health effects of exposure to IR are due to the free 
electrons produced when the electromagnetic wave interacts with the atoms of the cell, causing 
damage to the biomolecules and inducing oxidative stress. If the radiation dose is high enough, 
severe damage to the structure of the cell leads to cell death immediately (195). At lower levels, 
DNA damage (either by directly interacting with the DNA macromolecule or indirectly through 
the production of reactive oxygen species) can result in delayed cell death, repair of the DNA 
and restoration of cellular function, or incorrect repair and the possible increase in cancer risk. 
Various non-targeted effects also occur. These effects are discussed in length in following 
sections.  
When exposure to radiation is relatively high (>1Gy acute exposure in humans), the 
symptoms of Acute Radiation Syndrome (ARS) become evident. The three classical syndromes 
of ARS include bone marrow syndrome (or hematopoietic syndrome), gastrointestinal (GI) 
syndrome, and cardiovascular (CV)/ central nervous system (CNS) syndrome (44). 
Hematopoietic syndrome begins with doses between 0.7 – 10Gy and is characterized by the 
destruction of bone marrow which results in infection and hemorrhage. GI syndrome occurs 
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following exposure >6Gy and results in extreme damage to the GI tract leading to dehydration 
and death within weeks. CV/CNS syndrome follows 20 – 50Gy doses, resulting in collapse of 
the circulatory system and increased cranial pressure; death occurs within days. The doses 
required to cause these syndromes reflect the radiosensitivity of the various tissues. The LD50/60, 
or the dose which is lethal to 50% of the population within 60 days, is approximately 4Gy, while 
the LD100 (lethal dose to 100% of the population) is around 10Gy (44).  
Human exposures to radiation 
Humans are exposed to radiation from a variety of natural and manmade sources. 
Natural background radiation sources include radioactive elements within the earth‟s crust, 
radon gas released from the earth, and cosmic rays. Small traces of naturally occurring 
radioactive materials, including 3H, 14C, 20K, can become incorporated into the biomolecules of 
the human body and become a source of internally emitted radiation. According to the United 
Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), the global 
average radiation dose from natural background radiation is approximately 2.4mSv (167, 268). 
The dose from natural background radiation can vary depending upon location. For example, 
inhabitants of Ramsar, Iran are exposed to 5 times more radiation from natural sources than the 
global average (268).  
Radiation exposure in the U.S. population is monitored by National Council on Radiation 
Protection and Measurements (NCRP). The NCRP recently re-assessed the exposure from all 
radiation sources in the U.S., updating their last report published in 1987 which used data from 
1980 to 1982 (189). In the last 30 years, the estimated annual per-capita dose to the U.S. 
population has almost doubled, from approximately 3.0mSv to 5.6mSv (189). While the average 
dose from natural sources has remained constant, there has been a dramatic increase in the 
average radiation dose from medical radiation procedures. This is mainly due to the increased 
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use of computed tomography (CT) scans, and it is estimated that >62 million CT scans are 
performed in the U.S. per year (189). CT scans account for approximately half of collective dose 
from all medical procedures.  
The doses associated with conventional x-ray procedures is relatively low, approximately 
0.1mGy for a typical chest x-ray (Table 2-1) (33). In comparison, a typical abdominal CT scan 
can deliver 50 times more radiation. Spiral CT scanning, which is used for the detection of 
potential disease in asymptomatic individuals, is becoming more common. A full-body spiral CT 
scan can deliver up to 100mGy (184),  although newer techniques are being developed which 
reduces the radiation dose (52). There is intense debate concerning the cancer risk from CT 
scans, an issue which is discussed in detail below. 
Epidemiological data for radiation exposure 
Atomic bomb survivors 
One of the largest cohorts for evaluating radiation risk is the Life Span Study (LSS) 
cohort which consists of approximately 86,000 survivors of the Hiroshima and Nagasaki atomic 
bombs of 1945. A couple of years after the bombings, the U.S. Atomic Bomb Casualty 
Commission was formed and followed the health of survivors, being particularly interested in the 
hematological consequences of the radiation exposure. In 1952, the first paper observing the 
excess of leukemia among the survivors was published (82).The LSS was created shortly 
afterwards to study mortality and cancer incidence among survivors. The Radiation Effects 
Research Foundation (RERF), a non-profit Japanese foundation supported by the U.S. and 
Japanese governments, oversees the LSS. The advantages of the LSS cohort is its large size, 
the long follow-up period after exposure, the inclusion of both sexes and all age groups, the 
range of radiation dosage, and the accuracy and completeness of mortality data. This data has 
been used to estimate radiation-induced risks for various cancers (and non-cancerous   
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Table 2-1. Approximate mean doses for societally-relevant radiation exposures. 
 
Source Dose 
Radiotherapy to tumor (multiple fractions) 40-70Sv 
Exposure on international space station 170mSv / year 
Upper limit for full-body spiral CT scan 100mSv 
Cranial CT scan 50mSv 
Limit for radiation worker exposure 20mSv / year 
Mammogram 3mSv 
U.S. dose from medical sources 3.0mSv / year 
U.S. dose from natural sources 2.4mSv / year 
Chest x-ray 0.1mSv 
Round-trip flight, New York to London 0.1mSv 
 
 
Data obtained from Brenner, et al., 2003 (32), Mullenders, et al., 2009 (184), and Mettler 
et al., 2009 (167). 
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diseases) across a range of doses. The estimated average for the cohort is estimated to be 
approximately 20cGy (214), although individual exposure varied widely and estimates are poor 
guesses at best. 
The data for the cohort increases over time due to the latent development of cancer and 
due to mortality (and therefore cause of death information) of the bomb survivors. Therefore, the 
LSS continues to be a source for updated epidemiological studies. The radiation-induced cancer 
risk is being continually re-assessed using updated dosing estimates and new modeling 
statistics.  
The most recent report from the RERF on solid cancer and non-cancer disease mortality 
was published in 2003 (214). In the 47-year follow-up, there were 9,335 deaths from solid 
cancer and 31,881 deaths from non-cancer diseases. It was estimated that 5% of the solid 
cancer deaths were associated with radiation exposure, noting that relative risks decline with 
increasing attained age and are highest in those who were exposed as children. This could 
translate into a 47% increased risk for the development of solid cancer by age 70 for those 
exposed to the radiation at 30 years of age (214).  
Pierce & Preston specifically analyzed cancer risk of low radiation doses in the LSS 
(211). Their study included 7,000 cancer cases among 50,000 survivors, most of whom 
received a dose less than 0.5Sv. They reported a significant increase in solid-cancer-related 
mortality in individuals who received 5-125mSv (P = 0.025). The authors stress that their data, 
which involved direct assessment of cancer incidence in the low dose cohort, did not involve 
any linear extrapolation. They suggest that other estimates of cancer in the LSS using linear risk 
estimates from a wider exposure range do not overestimate low-dose risks, an issue of intense 
debate in the low dose radiation field.  
A recent study analyzed 310 deaths due to leukemia during period from 1950 – 2000 
among 86,611 in the LSS (216). Using survivors with an estimated exposed dose >0.5cGy as a 
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reference (i.e., “control”), Poisson regression methods were used to evaluate the associations 
between estimated bone marrow radiation dose and leukemia mortality. Overall, the authors 
estimate that 103 of the 310 observed leukemia deaths were due to radiation exposure. They 
also suggest that radiation-induced leukemia death is still persistent in the cohort some 50 years 
after the bombings, a conclusion based on the most recent leukemia deaths.  
The incidence of leukemia and solid cancers among the cohort was recently analyzed by 
Dropkin, where he specifically looked at cancer mortality in survivors exposed to <20mSv (72, 
73). This is within the range of the International Commission on Radiological Protection‟s (ICRP) 
current recommendation for annual occupational radiation dose (maximum average of 20mSv 
per year averaged over 5 years with no single year exceeding 50mSv) (106). He concluded that 
liver and urinary cancer mortality risk follows a linear dose response at the low doses, while the 
risk for 5 other cancers (stomach, liver, lung, pancreas, and leukemia) follows a non-linear 
model with a higher risk at low doses than what would be predicted with a linear model. Dropkin 
suggests that the increased cancer risk following exposure <20mSv casts doubts on the ICRP‟s 
current annual occupational limit.  
Radiation workers 
In addition to the atomic bomb survivors, radiological workers provide a separate, unique 
population to study the cancer risks of LDR. Compared to the LSS, studying radiation workers 
allows for a more direct assessment of the risks of LDR. Many countries have strict regulations 
concerning the maximum radiation dose for radiation workers and require carful dosimetry to 
monitor exposure. Therefore, radiation workers provide a unique irradiated population whose 
exposure dosages are relatively well estimated. In addition, the exposures of radiation workers 
are generally of smaller dose compared to the atomic bomb survivors and are protracted over 
extended periods of time at a low dose rate. Many studies have shown an increase in leukemias 
in workers exposed to LDR (42, 243, 304). While dosimetry is more accurate in radiation worker 
12 
 
studies compared to the estimates in the LSS (in which dosages are primarily based on 
distance from the blast), dosimetry, mixed radiation types, and missing data for individuals still 
complicate analysis. For example, men who worked at Oak Ridge National Laboratory (ORNL) 
between 1943 and 1972 were found to have increased leukemia mortality (286), but adjustment 
procedures used to compensate for missing dose data suggested that effect of missing dose 
data resulted in an upward bias in dose-response coefficients (84). Indeed, one study including 
workers from the Hanford Site, ORNL, and Rocky Flats Weapons Plant concluded that the 
combined excess relative risk for leukemia was actually negative (-1.0 per Sv or ERR/Sv) (91). 
Of the 24 solid and non-solid cancer types tested, Gilbert, et. al. reported that half showed 
positive correlations and half showed negative correlations, as would be expected by chance 
fluctuations (91).The International Agency for Research on Cancer has coordinated studies in 
which radiation worker data from multiple countries are integrated together to form larger 
cohorts which increase power in detecting risk. One of the first such analysis included >95,000 
workers from combined data of three registries from the United States (including Hanford, 
ORNL, and the Rocky Flats Plant), the United Kingdom (including the Atomic Energy Authority, 
Atomic Weapons Establishment, and Sellafield Plant), and Canada (Atomic Energy of Canada 
Limited) (42). Of all the cancers monitored, a significant association was observed only for 
multiple myeloma (one-sided P = 0.037, 44 deaths). More recently, a 15-country collaborative 
cohort was analyzed and included nearly 400,000 nuclear industry workers (278). A significant 
increase was found in cancer mortality (ERR/Sv = 0.90, 5,233 deaths), with a significant 
association for lung cancer (ERR/Sv = 1.86) and an almost significant association for multiple 
myeloma (ERR/Sv 6.15, 83 deaths, P = 0.06). However, the authors concede that other 
confounding factors (i.e., tobacco use) will need to be addressed in future studies (43). 
 In general, radiation workers can be an informative population for epidemiological 
studies regarding LDR risk, but there are important limitations which must be considered when 
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interpreting the findings. The first involves the potential for bias due to confounding when 
analyzing small risks (90), such as the ERR for multiple myeloma included only 83 deaths in the 
400,000 workers. Another limitation involves what is considered a strength of radiation worker 
analyses: dosimetry. Personal dosimeters worn by workers can induce various biases. Gilbert et 
al. noted that the dosimeters were designed for radiation protection and likely overestimates 
dose to bone marrow (important for leukemia risk estimation) and most other organs (92). In 
addition, workers exposed to low doses (<10mSv) represent only a small percentage of the 
workers within the cohort, complicating the risk following LD exposure (90).  
Radiotherapy patients 
Additional epidemiological radiation-exposure data come from cancer patients who have 
undergone radiation cancer treatment. The Surveillance, Epidemiology and End Results (SEER) 
Program collects and publishes cancer incidence and survival data from population-based 
cancer registries and includes approximately 26% of the U.S. population, making it a unique 
resource for evaluating the potential risk of subsequent cancers following radiation treatment 
(http://seer.cancer.gov/about/). According to the National Cancer Institute‟s 2006 report using 
data from the SEER Program, it is estimated that cancer patients who undergo successful 
treatment for cancer are at a 14% higher risk for developing a new malignancy compared to the 
rest of the population (62). Some of the increased risk is attributable to the radiation therapy 
employed to fight the cancer, but there are many other risks and variables which need to be 
considered before developing an accurate estimate of what proportion of these new cancers are 
caused by the radiotherapy itself. One of the largest factors involves the individual‟s genetic 
susceptibility to cancer. If an individual has a germline mutation in a tumor suppressor gene, for 
example, that individual has a much higher risk of developing additional cancers even if the 
original malignancy is cured. One striking example is seen in pediatric patients with 
retinoblastoma. For those patients with germline mutations in the tumor suppressor RB1 
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(retinoblastoma-1) gene (heritable retinoblastoma), the cumulative incidence for developing a 
new malignancy within 50 years is 36%, compared to only 5.7% in retinoblastoma patients with 
non-heritable retinoblastoma (120). Other factors include sex, race, type of primary cancer, and 
use of chemotherapy (62). Despite all of these compounding factors, it is still evident that the 
radiation treatment itself increases risk. Returning to the retinoblastoma example, it was 
estimated that the increased risk do to radiation treatment in non-hereditary retinoblastoma 
patients was 3.1 fold higher, representing a significantly increased risk for sarcomas, 
melanoma, various brain cancers, and cancer of the nasal cavities (120). Similar results were 
observed with increased risk of breast cancer in female patients who underwent radiation 
treatment for childhood Hodgkin‟s disease (21). The increased risk from radiation exposure is 
most clearly seen in the treatment of childhood cancers, due to the long latency seen for 
radiogenic cancers (62). These factors must be taken into account when determining follow-up 
procedures to monitor the development of new malignancies. It is important to note that there is 
a clear benefit for radiotherapy, which exceeds that of the risk of developing new neoplasms.  
Epidemiological studies, while providing the best estimates of radiation-induced cancer 
risks in the human population, reach their limit of detection of risk at doses at and below 
100mSv (184). More research on the biological effects of lower doses of radiation is needed in 
order to accurately assess risk at these levels of exposure, and it is clear that controlled 
experiments in humans are not possible, especially with the cohorts that are available. 
Radiation-induced cell damage and repair 
The biological effects of IR exposure are mediated through direct damage to 
biomolecules (e.g., energy directly deposited on the molecule) or indirectly through the 
formation of reactive oxygen species (ROS).  
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Molecular scavenging involves the mechanisms which prevent further radiation-induced 
damage from free radicals. ROS are formed by the radiolysis of intracellular water, which in 
turn, can cause oxidative damage to DNA, proteins, and lipids (196). However, the cell is always 
exposed to ROS as a byproduct of normal oxygen metabolism, and various defense 
mechanisms are in place for protection from ROS-induced damages. These include anti-oxidant 
molecules (e.g., glutathione, Vitamins C and E, NADPH) and enzymatic scavengers (e.g., 
catalase, superoxide dismutase). During times of oxidative stress (e.g., following radiation 
exposure), pro-oxidant production exceeds the cellular antioxidant capacity to maintain normal 
redox potential (239). The cell can respond by increasing the metabolic antioxidant capacity 
through the elevation of antioxidant levels. Increased levels of glutathione and superoxide 
dismutase (Sod) have been reported in mouse tissues following exposure to low dose radiation 
(197, 204, 251, 292). It has been suggested that radiation-induced oxidative stress not only 
contributes to cellular radiation damage, but that it is the trigger for IR-induced signaling and 
adaptive responses (246). Sustained oxidative stress can result in the continued, amplified 
oxidative damage long after the initial radiation exposure, which can lead genomic instability 
(246), discussed below. 
Radiation-induced DNA damage and its repair is perhaps the most studied effect of 
radiation exposure because excessive damage or inadequate repair can lead to cell death, 
genomic instability, or carcinogenesis. Ionizing radiation can either directly damage DNA (e.g., 
energy directly deposited on the DNA molecule causing single- or double-stranded breaks) or 
indirectly through ROS (resulting in DNA breaks or DNA adducts such as 8-oxo-7,8-
dihydroguanine) (213). There are two main schools of thought regarding the mechanisms which 
alter signal transduction and result in the activation of DNA repair mechanisms (270). As 
mentioned above, radiation-induced ROS and the subsequent alterations in intracellular redox 
reactions could be the trigger for the induction of signal transduction pathways. While the exact 
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mechanisms responsible are unknown, it has been hypothesized that NADPH oxidases could 
play a key role (246). The other school of thought involves the sensing of DNA damage by 
proteins such as Atm and DNA-PK, which in turn promote activation of receptors and signaling 
pathways and cell cycle checkpoints (270). It is likely that both mechanisms are involved in 
radiation response. 
While the exact mechanisms may not be fully understood, the cell must recognize the 
damage and respond appropriately, either by arresting the cell cycle, repairing the damage, 
and/or inducing apoptosis (Fig. 2-1). DNA double-stranded breaks (DSBs), the most deleterious 
form of radiation-induced DNA damage, are induced by radiation several fold above 
endogenous levels in a linear dose-dependent manner, even at very low doses (1mGy in vitro 
and 100mGy in vivo) (219). Once DSBs are formed, numerous DSB repair proteins are 
recruited to the break which creates a stabilizing complex that is vital for DSB repair and 
checkpoint activation (271). Decreased efficiency of DSB-repair is linked with radiosensitivity 
and has been proposed as a means of identifying patients who are more susceptible to radiation 
toxicities prior to cancer radiotherapy treatments (221).  
Ataxia telangiectasia mutated (Atm) kinase is a critical DNA-damage signaling enzyme. 
Following DNA damage, Atm undergoes rapid autophosphorylation and phosphorylates H2AX 
at the site of the break (15). This phosphoylated histone (γH2AX) provides a platform on which 
DSB response proteins bind and initiate repair (271). The essential role of H2AX in DSB repair 
is seen in the H2AX(-/-) mouse, whose DNA repair defects are correlated with increased 
radiosensitivity and genomic instability (45). ATM mutations are responsible for the human 
radiosensitivity disease ataxia telangiectasia, discussed below (224).  
Atm activates pathways which halt the cell cycle and initiate repair by phosphorylating 
downstream targets, including the transcription factor p53 and the checkpoint kinases Chk1 and 
Chk2 (220) (Fig. 2-1). DSBs can be repaired through homologous recombination involving   
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Figure 2-1. DNA damage response signaling mediated by ATM. 
(A) Radiation causes double-stranded DNA breaks (DSBs). The 
damage is recognized by “sensors” such as the MRN complex 
(MREII, RAD50, NBS1) and the signal is transmitted to “tranducers” 
such at ATM, which in turn pass the signal to “effectors” which 
activate various signal transduction pathways. DSBs can be repaired 
by homologous recombination (involving Rad51 and Rad52) or by 
non-homologous end joining (NHEJ). Image courtesy of Mullenders, 
et al., 2009 (184) (B) Activated ATM phosphorylates a series of 
downstream targets resulting in cell cycle arrest and DNA damage 
repair. Image courtesy of Lavin, 2008 (134). 
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Rad51, or through the more error-prone mechanism of non-homologous end-joining (NHEJ), 
which involves DNA-dependent protein kinase catalytic subunit (DNA-PKcs) (7, 103). Defective 
Atm leads to radiation hypersensitivity through inadequate DNA repair, and perhaps more 
importantly, through defective Atm signaling which results in compromised defense against DNA 
damage (134).  
It is well established that the p53 pathway is central to the DNA damage response. 
When activated through phosphorylation by Atm and DNA-PK, p53 activates cell cycle 
checkpoints which allows the cell to asses DNA damage and repair the DNA prior to replication 
or activate apoptosis (270) (Fig. 2-2). p53 can lead to cell cycle arrest through inducing the 
expression of cyclin-dependent kinase inhibitor 1A (Cdkn1a, also known as p21). The p53 – 
p21/Rb checkpoint axis leads to G1 arrest, allowing the cell to undergo DNA-repair before 
resuming the cell cycle (279). Rb has the potential to either mediate apoptosis or protect against 
it, which appears to be dependent upon the phosphorylation status of Rb, with 
hyperphosphorylated Rb correlated with low apoptotic rates and non-phosphorylated Rb  
correlated with high apoptotic rates (279). Differences in post-radiation phosphorylation status of 
Rb have been linked to differing apoptotic rates in C57BL/6J mice (279).  
Alternately, p53 can lead to apoptosis via the up-regulation of pro-apoptotic Bcl2-
associated X protein (Bax) (140). Bax induces cytochrome c release and caspase activation, 
thereby initiating apoptosis (218). It has been demonstrated that basal p53 transcription and 
protein level within a tissue partially determines its sensitivity to radiation-induced apoptosis 
(155). This response is also affected by genomic background, with mouse strains exhibiting 
varied apoptotic rates and susceptibilities to radiation-induced genomic instability (212, 223, 
279, 281). It should be noted that death of a damaged cell removes the possibility of the cell 
acquiring genomic instability and the formation of a population of daughter cells with gene and 
chromosomal abnormalities.  
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Figure 2-2. Activation of the p53 signaling pathway by radiation. p53 is a 
transcription factor whose activity is regulation by phosphorylation. Damage to 
DNA can lead to apoptosis via Bcl2 and Bax transcription. Alternately, Cdkn1a 
(p21) transcription can halt the cell cycle until DNA is repaired 
http://main.biocarta.com/pathfiles/h_p53Pathway.asp). 
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Genetic background and radiosensitivity 
Human radiosensitivity diseases 
It is well-known that individuals differ in their sensitivity to radiation, and the role of 
genetics in radiosensitivity is most evident in humans with radiosensitivity syndromes such as 
ataxia telangiectasia (A-T), Nijmegen breakage syndrome, xeroderma pigmentosum, and others 
(86). The mutated genes responsible for many of these diseases have been identified, revealing 
pathways and mechanisms of radiation response. 
A-T is an autosomal recessive disorder which is primarily an immunodeficiency disease 
(208), but radiosensitivity is also a hallmark of A-T (93). Other characteristics of the disease 
include cerebellar ataxia, oculocutaneous telangiectasia, bronchopulmonary disease 
susceptibility, lymphoid tumors, and insulin-resistant diabetes (134). The gene which is mutated 
in A-T (ataxia telangiectasia mutated, ATM) was identified in 1995 (224). As mentioned 
previously, ATM plays an integral role in the DNA-damage response, both in the signaling to 
DNA-repair machinery to repair DSBs and in signaling cascades leading to cell-cycle checkpoint 
activation. ATM also is involved in repairing the DSBs formed during gene rearrangement of 
immunoglobulin and T cell receptor genes. This V(D)J recombination mechanism is defective in 
A-T patients, which lead to chromosomal abnormalities in lymphocytes and development of 
lymphoid tumors (269).  
Individuals with Nijmegen breakage syndrome and ataxia-telangiectasia-like-disorder 
(ATLD) share some of the same DNA repair and DNA damage signaling defects with A-T 
patients. Nibrin (NBN, also known as NBS1), the mutated gene in Nigmegen breakage 
syndrome, is involved in the sensing of DSBs and the recruitment of ATM (274). NSB1, together 
with RAD50 and MRE11, form the MRN complex which binds to DSBs and undergoes 
conformational changes which activate ATM (205). ATLD also involves disruption of the MRN 
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complex but via MRE11 (258). Thus, it is not surprising that A-T, ATLD, and Nijmegen breakage 
syndrome patients display similar clinical symptoms.  
While A-T, ATLD, and Nijmegen breakage syndrome are due to defective DSB repair 
and signaling, xeroderma pigmentosum (XP) involves defective nucleotide excision repair 
(NER). XP patients have defects in one of several “XP genes”, all of which are involved in 
various steps in the NER pathway. Individuals with XP are particularly sensitive to DNA damage 
from UV radiation, resulting in a 1,000-fold increase in susceptibility to cancer (126).  
Mutations in TP53 (the gene which encodes p53) increases cancer risk. As the 
“guardian of the genome”, p53 is responsible for monitoring the integrity of the genome and 
inducing apoptosis in genetically damaged cells (132). It is estimated that more than 50% of 
human tumors contain a mutation or deletion of the TP53 gene (265). Some patients with Li-
Fraumeni (LF) syndrome carry inherited, heterozygous mutations of the TP53 gene which is 
correlated with high cancer risk (273). Cultured fibroblasts from patients with LF sustain less IR-
induced permanent G1 arrest than normal fibroblasts which leads to increased G1 chromosomal 
radiosensitivity (28).  
While many of these diseases are associated with increased cancer risk and 
substantially increased radiosensitivity, more subtle mutations in these genes, and other genes 
in these pathways, can lead to differences in acute tissue reactions in radiotherapy-treated 
patients (51).Determining the polymporphisms and/or mutations underlying genetic 
predisposition to radiosensitivity is an area of intense research, with profound implications on 
radiotherapy treatment and radiation exposure guidelines. 
Radiosensitivity and mouse models 
Striking variation in sensitivity to radiation is also apparent in murine models. In 1963 
Roderick published a seminal work on the differences in radiation sensitivity between inbred 
mouse strains (217). Beginning at 4 months of age, mice from 27 strains were exposed to daily 
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doses of 1Gy x-ray radiation until they died. The most susceptible strains, including CBA/J and 
BALB/cJ, succumbed to the radiation in approximately 16 days, while the most resistant strains, 
such as 129/J, survived more than twice as long. It has since been determined that the 
radiosensitivity of BALB/cJ mice is due in large part to two mutations in Prkdc, the gene which 
encodes the catalytic subunit of a DNA-break-dependent protein kinase (DNA-PK), resulting in 
decreased expression and enzymatic activity (298). As mentioned previously, DNA-PK is known 
to be involved in double-stranded break repair and signal transduction following exposure to IR 
(242).  
According to Roderick‟s study, C57BL/6J and DBA/2J have an intermediate 
radiosensitivity phenotype, differing in survival by an average of 3 days (217). By lowering the 
challenge dose as low as 5cGy, Nomura, et al. revealed significant differences between 
C57BL/6J and DBA/2J in radiation-induced apoptotic rates within various tissues (193). 
Numerous studies have highlighted the innate differences in radiosensitivity of the two strains, 
with C57BL/6J generally considered more resistant to radiation-induced genomic instability and 
DBA/2J more sensitive (193, 281, 288). Wright and colleagues determined that the strains 
exhibit differences in apoptotic rates in the spleen following whole body exposure to 1Gy x-ray 
radiation (279). These differences were found to be correlated with differential induction of 
p53/p21 pathways (57, 140, 279). C57BL/6J mice undergo early induction of p53 and 
subsequent up-regulation of pro-apoptotic Bax, while DBA/2J mice display a later but more 
prolonged p53 response and increased expression of Cdkn1a, leading to cell cycle arrest. The 
increased apoptotic rate in C57BL/6J prevents the incorporation of radiation-induced mutations 
and chromosomal aberrations into the genome and allows the tissue to return to homeostasis 
(140).  
While the BALB/cJ Prkdc mutations and human radiosensitivity diseases are examples 
of highly penetrant genetic variants which alter radiation response, it is assumed that radiation 
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sensitivity within the general population is due to the combinatorial effects of inherited genes of 
low penetrance, which are by nature more difficult to characterize, especially at low doses. 
Differing radiosensitivity between mice of different genetic backgrounds make them excellent 
models for understanding the underlying genetic networks responsible for radiosensitivity in the 
human population.  
Low dose radiation biology 
Importance and challenges of LDR biology 
While the biological effects associated with high dose radiation (HDR) exposure are 
fairly well characterized, the effects and long-term cancer risks from exposure to lower doses of 
radiation are less understood. As defined by the Department of Energy‟s Low Dose Radiation 
Research Program, low doses of radiation (LDR) are exposures at or below 10cGy. The LDR 
Research Program, the source of funding for this research, is particularly interested in the study 
of cellular and molecular responses to IR, particularly low-LET radiation, with doses at or near 
current workplace exposure limits (http://lowdose.energy.gov/).  
Standard epidemiological and toxicological approaches have been used for decades to 
attempt to characterize the health effects of LDR. However, the radiation doses of interest are 
just above natural background radiation levels, making measurable health risks to the human 
population arduous. In addition, the radiation endpoint of utmost concern, cancer, is a multi-
factorial process which takes years to develop. Therefore, the current exposure standards for 
the protection of the public and workforce have been set by using models to predict LDR-
attributable cancer risk from data obtained from much higher exposures (195).  
As mentioned above, the continued increase in the use of radiological imaging has 
exposed a larger portion of the U.S. population to radiation doses which are significantly above 
natural background radiation, but are still within the “low dose range.” A clear understanding of 
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the risks involved with LDR exposure is needed for a meaningful risk-reward analysis of such 
radiation exposures.  
Models for estimating LDR risk 
The currently accepted method for low-dose risk assessment endorsed by the U.S. 
National Academy of Sciences‟ Biological Effects of Ionizing Radiations (BEIR) VII report (195) 
and the International Commission on Radiological Protection (ICRP) is a linear-no-threshold 
(LNT) extrapolation of LD cancer risk from HD data. According to the LNT hypothesis, risk is 
directly proportional to radiation dose. This risk estimation model has formed the basis of human 
radiation protection practices since the 1960s (105). In support of this assumption, it has been 
shown that there is a linear relationship between DNA damage and radiation dose (219). LNT 
suggests that radiation-induced DNA damage accumulate over time and increase risk of 
carcinogenesis. This LNT principle is known as the “collective dose” concept, or “dose 
additivity”, which assumes that risk can only increase with additional exposure (169). LNT also 
assumes that cellular defense mechanisms are not influenced by dose or dose rate and that the 
mechanisms of carcinogenesis are the same for both HDR and LDR.  
However, an increasing amount of evidence questions the validity of the LNT model. 
Alternatives to the LNT model include the linear threshold model, in which there is a lower-limit 
radiation threshold below which there is no detectible risk (257, 262), and a non-linear model 
with decreased risk at LD levels, which takes into account the phenomena of hormesis. 
According to hormesis, low levels of radiation exposure can actually reduce risk to radiation-
induced detrimental outcomes, such as cancer, while the risk at higher doses of radiation is 
linearly correlated with dose (79). Numerous studies have shown that exposure to a low dose of 
radiation prior to a high dose actually decreases risk (65, 109, 232, 297), which is in direct 
opposition to the “dose additivity” tenant of the LNT model. In contrast, other radiation effects, 
25 
 
such as transmissible genome instability and bystander effects (both discussed below), could 
result in an increase cancer risk at low doses, and therefore, the LNT would under-estimate 
LDR risks (141). Accurate assessment of risks from LDR exposure is essential for the 
development of adequate radiation exposure limits imposed by governments. 
The LDR Research Program provides funds to projects which directly test the 
mechanisms and pathways involved in low dose radiation response at a systems level in order 
to ascertain the radiation-induced perturbations of normal physiology. The overall goal is to 
characterize an organism‟s radiation response through all levels of biological organization, from 
genes and genomes to cells, tissues, and the organism as a whole. From these data, low dose 
radiation risk can be more easily and accurately predicted for an individual as opposed to a 
simple, linear extrapolation from high dose radiation risk.  
CT scan debate 
As mentioned above, the American population is exposed to an ever increasing amount 
of radiation through medical imaging procedures. This has raised concern over the increased 
cancer risk from diagnostic radiology, especially that of CT scanning. In a 2007 landmark (and 
very controversial) report published in The New England Journal of Medicine (NEJM), Brenner 
& Hall concluded that within a few decades, 1.5-2% of all cancers within the U.S. population 
could be caused by the current rates of diagnostic CT (33). This conclusion was reached by 
using a LNT model of extrapolating LD from atomic bomb survivor data (229). They also point 
out that children exposed to IR from medical imaging are at higher risk than adults. The results 
of this article were made known to the general public through large media outlets, and a heated 
debate within the professional radiation research and medical fields ensued. Those who argued 
against the conclusions of Brenner & Hall‟s results cited errors in the methodology used to 
estimate the risk. Shortly after the original publication, The NEJM published three letters to the 
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editor from leading radiation researchers who questioned the validity of the LNT extrapolation 
model used to compute risk (78, 187, 263). In addition, Scott et al. published a lengthy editorial 
in which they critique the assumptions and methods used by Brenner & Hall (229). Scott et al. 
focused on the adaptive responses of humans to IR, a topic which is discussed in detail later, 
and concluded that there is evidence that radiation exposure from CT scans could reduce the 
risk of cancer development among irradiated adults. While they do concede that the impact of 
diagnostic radiation exposure on children is less clear, Scott et al. discount the validity of the 
LNT model-based risks estimates derived for children by the extrapolation from atomic bomb 
survivors. In a very recent editorial in The NEJM, Brenner emphasizes that CT imaging is 
overused, and effective non-radiological imaging methods (i.e., magnetic resonance imaging, 
MRI) are sufficient diagnostic tools in many situations (31).  
Responses to LDR 
Non-targeted effects and adaptive responses modulate cellular responses to both HDR 
and LDR (176). Here these effects are discussed within the context of shaping the dose-
response curve at low doses of IR.  
Non-targeted effects: Genomic instability and bystander effects 
Radiation‟s carcinogenic potential is not just a result of DNA damage and subsequent 
misrepair of the damage as once believed, but it is also a result of non-targeted effects in that 
biological effects of radiation exposure can be observed in cells whose nuclei were never 
directly irradiated (174, 175). These non-targeted effects, also known as epigenetic effects, are 
heritable genetic changes that are not primarily a result of DNA sequence modification (276). 
Non-targeted effects include genomic instability and bystander effects, both of which can 
exaggerate the effects of LDR and result in a supralinear dose-response curve at low doses.  
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Radiation-induced genomic instability (RIGI) is a delayed, long-lasting effect of IR 
exposure that is characterized by a high levels of non-clonal mutations in the apparently healthy 
cells which survived the radiation exposure (183). The genetic alterations include mutations, 
deletions, chromosomal rearrangements, micronuclei formation gene amplification, and cell 
killing. Chromosomal instability is probably the most obvious alteration and the best 
characterized. Genomic instability is evident in most cancers and is observed in pre-malignant 
states, and thus appears to play a role in carcinogenisis (148). Understanding the initiation and 
perpetuation of RIGI may reveal some of the mechanisms of radiation-induced cancer formation 
(119).  
Genomic instability following low dose radiation exposure is thought to involve bystander 
effects. Radiation-induced bystander effect (BSE) is a non-targeted effect where non-irradiated 
cells exhibit typical radiation responses, e.g., chromosomal instability (RIGI), cell death, DNA 
damage response signaling, etc. (183). Considerable inter-individual variability in the elicitation 
and response to RIGI has been observed (182). Proposed mechanisms for RIGI effect involve 
gap junction communication and the release of soluble factors by irradiated cells.  
Bystander effects are studied in vitro by a variety of methods including co-culturing 
irradiated and non-irradiated cells, transferring media from irradiated cells to non-irradiated 
cells, using very low doses of α-particles such that not every cell receives an α-particle, or using 
a focused microbeam irradiator (183). Bystander effects were first demonstrated in vivo using 
Patched heterozygous mice, which are susceptible to cerebellar tumor formation which is 
accelerated with irradiation (160). When Mancuso and colleagues developed a lead shield to 
protect the brains of the mice during irradiation of the skin, there was an unexpected 
enhancement of cerebellar tumor formation. DSBs and apoptotic cells were observed within the 
shielded cerebella. They provided evidence of gap-junctional intercellular communication of the 
bystander effects in the central nervous system (160). Wright and colleagues demonstrated a 
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genotype-dependent bystander effect by exposing normal hemaopoietic clonogenic stem cells 
to bone marrow-conditioned medium from irradiated mice (151). The descendants of the 
hemaopoietic cells demonstrated chromosomal instability while the descendants of the directly 
irradiated cells did not. This effect was genotype-dependent because it was observed in bone 
marrow cells from CBA/Ca mice, who are susceptible to radiation-induced acute myeloid 
leukemia (r-AML), but not in C57BL/6 mice, who are resistant to r-AML. The source of the 
bystander effect was determined to be macrophages through a signaling mechanism which 
involved tumor necrosis factor-α, nitric oxide, and superoxide (151). Other data supports 
mechanisms involving cytokine signaling, specifically transforming growth factor-β (165) and 
oxidative stress due to mitochondrial dysfunction (119). Interestingly, irradiation of cell culture 
medium alone (e.g. in the absence of cells) with alpha particles can also induce bystander 
effects (138). 
Adaptive responses 
A sub-lethal exposure to radiation which is above background elicits stress responses 
and stimulates adaption. The adaptive responses can provide protection for the cell/organism, 
e.g., the hormesis effect. Adaptive protection develops within a few hours after exposure but 
may last for several months or weeks depending on the mechanisms and tissues involved and 
appear to have maximum effectiveness at about 10cGy total dose (Fig. 2.3) (79). Adaptive 
responses to radiation involve molecular scavenging, molecular repair, and removal of damaged 
cells (79, 80). Molecular scavenging involves oxidative stress response, and molecular repair 
mainly involves DNA repair (see Radiation-induced cell damage and repair section above). 
Adaptive protection is discussed in terms of hormesis. There are three main types of hormesis 
(40, 228):  
 Radiation conditioning hormesis: A small radiation dose activates protective 
processes which suppress harm form a subsequent, larger radiation dose  
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Figure 2-3. Adaptive protection from low dose (low-LET) induced 
adaptive protection. (A) LDR may induce adaptive responses affecting 
various levels of biological organization which can occur within hours of 
exposure and last for several months. (B) DNA damage and apoptosis 
increase linearly with dose, but other adaptive protections have 
maximum effectiveness around 0.1Gy. Image courtesy of Feinendegen, 
2005 (79). 
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 Radiation hormesis: A small radiation dose activates protective processes and 
reduces harm below the spontaneous level. 
 Radiation post-exposure conditioning hormesis: harm caused by a large radiation 
dose (or another agent) is reduced when a subsequent small radiation dose is 
administered.  
 
Generally, discussions of “adaptive responses” are referring to radiation conditioning 
hormesis. The first demonstration of radiation conditioning hormesis was published in 1984 
(198). Olivieri et al. reported that when human lymphocytes were cultured with radioactive 
thymidine (a source of low-level β-radiation at a total dose of 150cGy) prior to a 1.5Gy x-ray 
exposure, fewer chromatid aberrations were observed compared to lymphocytes not pre-
cultured with radioactive thymidine. The authors speculated that cellular defenses or repair was 
increased following the low dose exposure, or “priming dose”, which protected the cells from the 
higher dose, or “challenge dose”. This effect has also been demonstrated in vivo (65, 112, 170, 
171). The protective effect is time-dependent and dose-dependent. For example, when a 
50mGy priming dose was given to C57BL/6J mice prior to a mid-lethal (5.9Gy) challenge dose, 
the protective effect (e.g., increased survival) was observed when the challenge dose was given 
1, 3, or 7 days later but not 6 hours or 3.5 weeks later. A variety of priming doses were tested 
(50-400mGy), but the hormetic effect was only observed at the 50mGy dose (112). However, 
priming doses as low as 0.001mGy have been observed to induce adaptive responses prior to a 
1Gy challenge dose (65). Interestingly, the adaptive response was also evident if given when 
the high dose was given prior to the low dose (65), an example of radiation post-exposure 
conditioning hormesis. These adaptive responses have also been described in the lymphocytes 
of people exposed to clinical radiation (173) , and occupational radiation (18), as well as those 
exposed in the Chernobyl accident (200). It is important to note that there is considerable 
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variability in the adaptive response between individuals (25, 215), and it is clear that dose rate 
as well as absorbed dose and radiation quality are primary variables. 
The first demonstration of a pronounced radiation hormesis effect was more that 30 
years ago (267). Gamma irradiation was shown to decrease neoplastic transformation in RFM 
mice, which have a high rate of spontaneous lung-cancer and exhibit high genomic instability 
burdens, but evidently the authors attributed the results to systematic errors in their lung cancer 
detection methodology (228). The first report of in vitro radiation hormesis was by Edouard 
Azzam in 1996 (13). Mouse embryo fibroblasts had a three- to four-fold decrease in the rate of 
spontaneous neoplastic formation when exposed to a single LD x-ray exposure (as low as 
0.1cGy). This finding suggested that LDR can induce cellular processes which protect the cell 
from naturally occurring alterations which lead to cellular transformation. Since then, numerous 
studies have demonstrated a radiation-induced cancer protection (41, 98, 101, 122, 143, 170, 
194). Many of these effects are thought to involve radiation-induced modulation of the immune 
system, which is discussed in detail below.  
Impact on LDR-response models  
Both bystander effects and adaptive responses are potential modifiers of low dose 
radiation risk, neither of which is taken into account in linear extrapolation of risk from HDR 
data. However, the two phenomena appear to have conflicting effects on LDR risk. BSE tends 
to exaggerate the effects of LDR by eliciting detrimental effects to non-irradiated cells, while 
adaptive responses following LDR are protective. Both effects can impact the shape of the dose 
response curve at low doses, but how these two phenomena interact and effect overall LDR risk 
is unclear.  
An example of the interaction between a particular BSE and adaptive response in 
human–hamster hybrid AL cells was reported by Zhou et al. (303). A priming dose of x-rays 
given 4 hours before α-particle irradiation with a microbeam significantly decreased bystander 
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mutagenic response in the nearby cells which did not receive the α-particle irradiation. 
Therefore, the adaptive response decreased the bystander mutagenesis. However, bystander 
cells demonstrated an increased sensitivity following an additional challenge with x-rays. The 
authors concluded that LDR biological responses are a result of a complex interaction between 
directly induced radiation effects, bystander effects, and adaptive responses. Because these 
interactions are poorly understood, some radiation biologists believe it is premature to 
determine if the LNT model overestimates or underestimates the risk at low doses of radiation 
(176). 
LD enhancement of immunity 
There is no doubt that high doses of radiation results in immunosupression, which is 
often attributed to lymphocytes being particularly sensitive to radiation-induced apoptosis (166). 
However, numerous studies have indicated that LDR can actually be immunostimulatory. In 
humans, this is demonstrated in the treatment of chronic lymphocytic leukemia and low-grade 
non-Hodgkin‟s lymphoma (222). Typical treatment regiments include low dose fractions (0.1 – 
0.25Gy) which are given several times a week for a total dose of approximately 1.5Gy. This low 
dose rate is as effective in inducing long-term remission as chemotherapy treatment (113). 
Generally high doses of radiation are given during radiotherapy treatments because HDR is 
much more effective at cell killing. The effectiveness of the LDR treatment in these cancers 
therefore appears contradictory. It has been proposed that the efficacy of the LDR treatment is 
not due to direct cell killing, but rather an enhancement of immune system function (222). In 
other words, the LDR stimulates the immune system to recognize and kill the cancerous cells. 
There are numerous studies in experimental rodents which demonstrate a similar effect in that 
LDR can protect against tumor growth and metastasis in an immune-mediated fashion (41, 98, 
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101, 122, 143, 194). As mentioned above, these studies demonstrate radiation hormesis. The 
immune system enhancement has been demonstrated through (77, 222) :  
 The augmentation of immune cell proliferation in response to a mitogenic 
stimulus (8, 111, 192, 201, 234)  
 The alteration of cytokine release (98, 104) 
 Changes in expression of receptors on immune cells (144, 145) 
 Enhancing signal transduction pathways in lymphocytes (146) 
 
The modulation of immune response by LDR is dependent upon a number of factors 
including total dose (145), dose rate (109), and genetic background (234). In addition, the 
biological parameter of interest likely demonstrates a temporal relationship with the other factors 
(143).  The dose-response curve can also be vastly different between various target cells. For 
example, lymphocytes and their related functions usually follow a “J” shaped curve, while 
macrophage activation may demonstrate a curve with one or more peaks across a given dose 
range (143). Therefore, experimental design is key when assessing the dose-response 
relationship of immunological parameters (143).  
The immune system response is the result of a complicated interaction between multiple 
cell types within the context of the organism. We begin with a brief overview of the anti-tumor 
and ant-metastasis effects of LDR, followed by a review of the reported LDR effects on 
particular immune cell populations.  
Anti-tumor & anti-metastasis effects of LDR 
As mentioned above, LDR has been shown to protect against tumor growth and/or 
metastasis in a number of in vivo mouse models. There are three general experimental models 
used to test for these effects.  
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The first experimental design takes advantage of mice models which have a high 
spontaneous cancer, such as Trp53(-/+) mice. These mice have a high incidence of lymphomas 
and osteosarcomas. Mitchel et al. measured the effects of a single LD (1 or 10cGy) γ-irradiation 
on lymphoma and osteosarcoma frequency and latency in Trp53(-/+) (171). Radiation exposure 
had no effect on tumor frequency, which indicated that the radiation treatment had no effect on 
tumor initiation and thus all tumors were assumed to have formed spontaneously. Mice which 
received the lower radiation dose (1cGy) had significantly increased tumor latency for both 
lymphoma and osteosarcoma compared with control, indicating that the LD exposure reduced 
the rate of malignancy in the spontaneously-initiated tumors. Interestingly, the higher dose 
(10cGy) delayed lymphoma latency longer than the lower dose, but it decreased osteosarcoma 
latency compared to controls. This study suggested that the 10cGy dose could increase or 
reduce risk of metastasis, depending on the tumor type. Therefore, increased tumor surveillance 
could have been enhanced by the LDR.  
Another common experimental design involves the injection of tumor cells into LDR-
treated mice. For example, a study by Hosoi & Sakamoto demonstrated that mice which 
received low doses of radiation prior to or just after tail injection of squamous cell carcinoma 
cells developed a significantly fewer lung tumors compared to controls (101). The effect was 
observed for doses of 15 – 20cGy given from 9 hours before to 3 hours after the tumor cell 
injection. A similar suppressive effect was also observed in the spontaneous lung metastasis 
(101). 
Lastly, there are a few examples in which high dose cancer induction was suppressed 
by pre-irradiation with LDR. In one such study, Ina et al. monitored the induction of thymic 
lymphomas following exposure to high doses of fractioned X radiation (totaling 7.2Gy) in 
C57BL/6 mice which were pre-irradiated with 7.5cGy x-rays given 6 hours prior to each high 
dose irradiation (109). Sixty-three percent of the mice which received LDR prior to each HD 
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irradiation developed thymic lymphomas, compared to 90% of the mice who only received the 
HD irradiations. The lymphoma frequency was further suppressed to 43% in mice which 
received continuous γ-radiation (at 1.2mGy/hr) beginning 35 days prior to the first challenge 
dose. These results demonstrate a LDR-mediated decrease in tumor induction. Enhanced 
immune activities, as measured by increases in B cells, CD4+ T cells, and antibody-producing 
cells in the spleen following immunization with sheep red blood cells, were observed in the 
continuously-irradiated mice (109).  While tumor immunity is a very complex process, the 
parallel between tumor suppression and enhanced immune function suggests the involvement 
of immune activation in tumor suppression by low dose radiation (109), although the specific 
mechanisms involved remain to be determined.   
It is hypothesized that immune system activation plays a key role in the LDR-induced 
suppression of tumor induction and metastasis. Numerous studies have looked at the effect of 
LDR on specific immune cell populations (i.e., T cells, B cells, macrophages, etc.), as discussed 
below.  
LDR effects on T cells 
Cells of the immune system are some of the most radiosensitive cells in the body (96). 
Radiation exposure results in alterations in lymphocyte counts, but it appears that lymphocytes 
within the mouse spleen are affected differently than those in the blood (206). Specifically, the 
numbers of CD3+ T cells decrease in the blood of mice in a dose-dependent manner at 
moderate and high doses (0.5 – 3Gy γ-rays), while splenic T cell counts are only decreased with 
high doses. CD19+ B cell counts are depressed in both the blood and the spleen at high and 
moderate doses (206). Interestingly, it appears that some radiation-induced changes in 
lymphocytes can persist chronically in humans, as is seen in atomic bomb survivors (high dose 
and high dose rate). Flow cytometry analysis of peripheral blood of survivors demonstrate 
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significant reductions in T helper (Th) cells, but not T cytotoxic (Tc) cells or B cells (129). Others 
have demonstrated a decrease in T cell reactivity to mitogens and allogenic cells (2), and in the 
frequency of cells which secrete type 1 cytokines (128) in survivors. Depression or dysfunction 
of these lymphocytes can lead to serious health consequences, even increasing the risk for 
cancer (95). However, as mentioned above, there is evidence that exposure to low doses of 
radiation can stimulate the immune system, particularly T cells, which are perhaps the most 
studied target cell of the LDR effect on immune system function. 
One of the first demonstrations of LDR-induced augmentation of immune cell 
proliferation in response to a mitogen was reported in 1982 by Anderson & Troup (8). 
Splenocytes from LDR-exposed mice showed an increased response to various mitogens, and 
the authors suggested that T cells were the most responsive. Later it was confirmed that T cells 
were the primary cellular target of the LDR-induced proliferation augmentation (192). It was also 
shown that these target T cells expressed high levels of heat-shock proteins (Hsp-70 and Hsp-
72) compared to those of controls. Furthermore, the T cells from LD-irradiated mice responded 
to stimulation by anti-CD3 antibodies by further up-regulation of these genes and proliferating 
more extensively compared to the T cell of sham-irradiated mice (192). Chronic exposure to low 
dose radiation has also been shown to activate lymphocytes. In mice exposed to a low-dose-
rate (1.2mGy/ hour) of γ-radiation, CD4+ T cells and CD8 expression on CD8+ T cells were 
significantly increased, while B cells were significantly decreased (108). It has been suggested 
that the increase in “pro-mitogenic” effects which are evident following LDR are masked at 
higher doses due to an increase in thymocyte apoptosis (164).  
One of the proposed mechanisms for the LDR enhancement and HDR inhibition of T cell 
activation involves alterations in signal transduction in lymphocytes. Total-body LDR has been 
shown to increase expression of TCR/CD3 molecules, up-regulation of the transcription factors 
c-fos and c-jun, and increase expression of interleukin-2 receptor (IL2R) on thymocytes (144). 
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LDR has also been shown to up-regulate the CD28 receptor on T cells (145). The CD28 
receptor binds to the B7 ligand on antigen presenting cells (APCs), which is itself up-regulated 
following exposure to LDR or HDR. The interaction between CD28 on the T cell and B7 on the 
APCs leads to activation of the T cell, and therefore, immune function enhancement. In contrast, 
HDR exposure results in a down-regulation of CD28 and an up-regulation of CTLA-4, another 
B7 receptor which can lead to the down-regulation of T cell proliferation.  
There is evidence that CD4+ T cells are especially vulnerable to radiation exposure (94, 
206). In a recent paper, Gridley et al. analyzed the effects of low dose rate photons at low 
dosages (1cGy, 5cGy, and 10cGy) on lymphocytes in the blood and spleen of mice following 
total body exposure (96). Interestingly, T cells, B cells, natural killer (NK), CD4+ T cells, and 
CD4:CD8 T cell ratio in the spleen were depressed at all doses 21 days post-irradiation, but 
total T cells, CD4+ T cells and NK cells were increased in the blood. The greatest effect was 
seen in the CD4+ subpopulation in the 1cGy group. The authors speculate that low CD4+ cell 
number in the spleen triggered homeostatic mechanisms in order to regain balance in the 
subsets. The authors also performed gene expression analysis on the CD4+ cells isolated from 
spleen 1 – 2 hours post-irradiation, and found LDR results in a significant down-regulation of 
Inha, the gene which encodes the alpha subunit of inhibin, a member of the transforming growth 
factor beta (TGF-β) superfamily. Inhibin “inhibits” interferon-γ (IFN- γ) and interleukin-12 (IL-12) 
production by Th1 and dendritic cells, and it increases IL-4 and IL-10 production in Th2 cells. 
Thus, down-regulation of Inha suggests a shift in the Th1/Th2 balance towards the Th1 
phenotype. Because Th1 cells are involved in cell-mediated immunity, low dose radiation 
exposure could enhance responses against virus-infected and enhance tumor immunity (95). 
Conversely, HDR has been shown to shift the Th1/Th2 balance towards the Th2 phenotype 
(284). 
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The effect of LDR on lymphocytes has also been shown to be dependent upon genetic 
background. Shankar, et al. demonstrated different reactivities in the splenocytes of C57BL/6J 
and DBA/2J mice following LDR (234). Spleenocytes, particularly CD8+ T cells, from LDR-
exposed C57BL/6J mice showed an augmented response to Concanavalin A (Con A) compared 
to controls, while the opposite effect was demonstrated in LDR-exposed DBA/2J mice. The Con 
A-stimulated spleenocytes from C57BL/6J irradiated mice demonstrated a reduction in p53 
expression and reduced apoptosis compared to those from DBA/2J mice. Interestingly, the 
responses were shown to be dependent upon the mitogen used. When spleenocytes were 
challenged with Mycobacterium vaccae, C57BL/6J LDR-exposed mice demonstrated a 
suppressed response while BALB/c LDR-exposed mice had an augmented response. Thus, the 
LDR-induced alteration in lymphocyte activation appears to dependent upon antigen and 
genetic background. It also appears that p53 expression and induction of apoptosis appears to 
be involved in the differential responses (234).  
Natural killer (NK) cells also play a key role in tumor immunity (127). High doses of 
radiation have been shown to impair NK cell activity (202), while LDR has been shown to 
increase NK activity (122). The enhancement of NK activity by LDR has been shown to delay 
tumor growth. The induction of antioxidant mechanisms, particularly glutathione, may play a role 
in the modulation of NK activity (122).  
LDR effects on macrophages  
The effect of low dose radiation on macrophage function is not as well characterized as 
the effects on lymphocytes, and there have been conflicting reports on whether LDR increases 
or decreases macrophage-mediated inflammation. Irradiation with a moderate radiation dose 
(0.5Gy) of x-rays has been shown to decrease macrophage oxidative burst in vitro, which could 
translate into reduced inflammation following radiation exposure in vivo (227). This effect, 
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however, is likely to be dose-dependent, and “low” doses (e.g., ≤10cGy) were not examined in 
that study. In contrast, LDR has also been shown to enhance the phagocytic activity of 
peritoneal macrophages (201), which could result in increased protection from a subsequent 
infection, for example. It has also been shown that macrophages isolated from LDR-exposed 
mice have enhanced cytolytic activity, as measured by the ability to kill L1 sarcoma or P815 
mastocytoma cell targets in vitro (194). This enhancement may be at least partially due to 
increased amounts of nitric oxide released into tumor cell targets. This modulation of 
macrophage function could play a role in the LDR-induced inhibition of tumor metastasis, as the 
LDR-exposed mice also had suppressed development of experimental tumor colonies (194).  
 It has been demonstrated that total-body irradiation across a wide range of doses (0.05 
– 6Gy) activates the Toll signaling pathway in peritoneal macrophages, which results in 
sustained stimulation of the pro-inflammatory cytokines IL-12 and IL-18 (233), as well as TNFα 
and IL-1β (252). The expression of the surface molecules CD80 and CD86 on macrophages is 
also increased following exposure to both low and high doses of radiation (116). Because 
macrophages respond similarly to radiation exposure regardless of dose, it is assumed that 
differential changes in immunity following LDR and HDR does not reside in the direct response 
of macrophages (233). 
Other studies have suggested that the effects of LDR on macrophages are mainly 
indirect in that they are dependent upon interactions with other cells. Liu et al. investigated the 
interaction between spleenocytes and peritoneal macrophages from mice exposed to 7.5cGy x-
rays (147). They reported a suppression of IL-10 expression in spleenocytes and a 
simultaneous increase in IL-12 expression by macrophages, which could contribute to a shift of 
the immune response in favor of Th1 differentiation. These data support the mechanism 
proposed by Gridley et al. using proton-radiation data (95). Another study suggested that LDR 
induces the release of IL-1β by irradiated macrophages which stimulates neighboring cells 
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(such as lymphocytes). These stimulated neighboring cells either release cytokines or interact 
directly with the macrophages to further stimulate them (104). This mechanism would also lead 
to the increased proliferation of lymphocytes.  
LDR effects on dendritic cells 
Additional support for the Th1 shift in response to LDR involves the role of dendritic 
cells. In one study, splenic dendritic cells (DCs) were pre-irradiated with 0.02-1Gy of γ-radiation 
and were cultured with allogenic T cells (236). The DCs which were pre-irradiated with 5cGy 
radiation demonstrated the highest proliferation capacity of T cells. Dendritic cells were shown 
to have increased production of Th1 cytokines, including IL-2, IL-12, and IFN-γ, which suggests 
that the LDR augments T cell activation capacity through the increased cytokine production by 
DCs. The authors speculate that LDR effects on DCs might cause a shift in naïve T helper cells 
to Th1 cells.  
Systems Genetics Approach to LDR 
Introduction to systems genetics 
As described above, exposure to LDR results in a variety of changes within the 
organism. Ionizing radiation can damage DNA, alter gene expression, activate signal 
transduction pathways, alter intracellular oxidative status, etc. which can, in turn, result in 
systems level changes such as altered immune function. All of these responses are anchored to 
heritable variation which predisposes an individual to particular radiation outcomes. Studying 
each of these biochemical, cellular, and genetic factors in isolation is very useful in 
understanding particular radiation responses. However, to borrow the words of Aristotle, “The 
whole is more than the sum of its parts.” In this case, a comprehensive characterization of the 
health effects of LDR cannot be constructed without a holistic approach within the context of the 
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organism. Here, we use a systems genetics approach to characterize the genetic effects which 
modulate LDR-induced immune responses.  
Systems genetics is an emerging branch of systems biology in which complex traits are 
analyzed using multi-scale phenotype data that is assembled into complex molecular and 
phenotypic networks in the context of genetic variation. The basic premise is that variations in 
DNA which associate with a particular disease or response (LDR in this case) impact the 
physiological processes involved with the response through molecular, cellular, tissue, and 
organism networks (238). Statistical methods and computational algorithms are employed to 
identify correlations between the multi-level phenotypes and the underlying genetic variants.  
Reference populations and QTL mapping 
Central to the experimental design of dissecting complex traits though a systems 
genetics approach is the use of a genetically heterogeneous population. Often genetic reference 
populations are used because they are genetically stable and therefore reproducible, allowing 
direct comparison of various treatments among genetically identical individuals. As a result, 
phenotypic data can be obtained over time from various experiments and investigators and 
integrated together. Once a sufficient number of polymorphisms within the population are 
identified and the data made publicly available, researchers do not have to undergo the arduous 
and costly task of genotyping individuals for each experiment.  
Recombinant inbred (RI) mouse strains are valuable genetic reference populations. A RI 
panel is created from the intercross and subsequent sibling mating of (typically) two inbred 
mouse strains (called “parental strains” or “parentals”), but as many as eight parental strains 
have been used, as seen in the Collaborative Cross (53). The generation of RI lines from two 
parental strains is initiated with the formation of F1 progeny from crossing of the two parentals 
(Fig. 2-4). When the F1 progeny are crossed to produce the F2 generation, the original parental   
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Figure 2-4. BXD recombinant inbred mice. (A) Mating scheme for the creation of the BXD 
recombinant inbred (RI) panel. The parental strains (C57BL/6J and DBA/2J) are mated to 
produce an F1 generation. F1 mating produces the F2 generation whose genome is a 
mixture of the parental strains. Brother-sister mating for more than 20 generations leads to a 
fixation of the genome. The resulting RI strains are genetically different from one another as 
each strain has a unique combination of loci from the parental genomes. (B) Genome 
locations of the ~3,800 polymorphic markers in the BXD RI panel. R/QTL (34) was used to 
produce a genetic map using the markers downloaded from GeneNetwork 
(http://www.genenetwork.org/).  
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genomes are shuffled due to meiotic recombination. Pairs from the F2 generation are randomly 
chosen and continuous brother-sister mating for more than 20 generations results in the fixation 
of the genome. The resulting recombinant inbred lines have a unique combination of loci as a 
result of the meiotic recombination in the crossing of the F1 generation. RI strains are  
valuable resources for mapping of Mendalian and quantitative traits. One of largest mouse RI 
panels is the BXD (C57BL/6J X DBA/2J) strain panel, which consists of 81 extant strains (207, 
259, 260). The publically available genotype data for the BXD panel consists of nearly 3,800 
informative single-nucleotide polymorphisms (SNPs) and microsatellite markers throughout the 
genome (235). These markers are distributed throughout the genome (Fig. 2-4B) and make 
identification of loci responsible for quantitative traits relatively straightforward and rapid. Within 
the next year, additional markers for the BXD panel will be made available based on informative 
SNPs identified using the Affymetrix-based Mouse Diversity array (293) and will include 
~580,000 SNPs (RW Williams, University of Tennessee Health Science Center, personal 
communication).  
Quantitative trait loci (QTLs) are stretches of DNA which are closely linked to genes 
which underlie a phenotype of interest. Typically QTL analysis is performed on complex traits, or 
traits whose variability is due to the interactions of multiple loci. A large number of polymorphic 
markers throughout the genome of the reference population are needed to have sufficient power 
for informative mapping. QTL mapping is based on the premise that individuals with different 
alleles at the QTL marker locus will have different phenotypic means (131). This process has 
been used to identify genomic regions underlying a variety of human diseases (70) and 
radiation phenotypes (63, 282).  
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Transcriptomics and genetical genomics  
Transcript levels also vary genetically and somatically within populations and are 
quantitative traits, with the loci associated with their abundance called expression QTLs 
(eQTLs) (48, 225, 226). Genetical genomics combines transcriptomics with standard QTL 
mapping to identify loci responsible for regulating gene expression (115). Transcriptomics, or 
the simultaneous quantification of all expressed transcripts within a cell or tissue, is made 
possible by technologies such as microarrays.  
Genome-wide transcriptional profiling can be used to identify genes whose expression is 
differentially regulated following radiation exposure, which can reveal the mechanistic 
responses employed by the cell to respond to the challenge. These responses are temporally 
regulated and have been shown to be tissue-specific (136), dose-specific (69), and genetic-
background dependent (60). By performing semi-quantitative reverse transcriptase PCR, Lee et. 
al demonstrated that the induction of LDR-responsive genes varied greatly between tissues of 
C57BL/6J mice following whole-body irradiation, indicated that genetic modifiers of radiation-
induced gene expression act differently in different tissues (136). The expression of some p53-
regulated genes, such as Cdkn1a, Gadd45a, and Mdm2, appears to up-regulated in response 
both LDR and HDR, but the magnitude of induction is dependent upon dose (4). Indeed, overall 
expression profiles following radiation exposure appear to be dose-specific (6, 69, 83, 149, 
237). For example, Ding et al. compared gene expression changes following low dose (2cGy) 
and high doses (4Gy) of x-ray radiation in normal human skin fibroblasts (69). They reported 
quantitative and qualitative differences in gene expression patterns between the two doses and 
dose rates (20cGy/min for LDR and 2Gy/min for HDR). The genes which responded to LDR 
involved functions relating to cell-to-cell signaling, signal transduction, and DNA damage repair. 
In contrast, those which responded to HDR were involved in apoptosis and cell proliferation. 
These dose-specific responses in cultured cells support a non-linear correlation between the 
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biological effects of high and low dose radiation exposures. In addition to being tissue-specific 
and dose-specific, radiation-induced gene expression varies depending on genetic background. 
Our lab performed spleen transcriptional profiling in six strains of mice following whole-body LD 
x-ray exposure and identified significant differences in the both number of genes exhibiting 
radiation responsiveness and in the pathways in which the genes function (BH Voy, et al., 
unpublished data). Others have described differences in expression depending on genetic 
variability in response to HDR (60, 241). A study which integrated global gene expression and 
various radiation survival parameters (including apoptosis) across the 60 cell lines of the 
National Cancer Institute Anticancer Drug Screen (NCI-60) demonstrated that a set of radiation-
induced cell cycle genes were commonly regulated across the panel, representing penetrant 
gene expression responses (5). Interestingly, they noted that radiosensitive and resistant lines 
were well discriminated by their basal expression patterns. They suggested that the basal 
expression could be even more informative of radiosensitivity than the radiation response 
signatures (5). Similarly, our lab analyzed differences in baseline spleen expression for 
correlation with various radiation outcomes. 
Data integration 
One of the advantages of using microarrays to assess transcript abundance is that the 
expression levels of all the genes are measured simultaneously allowing for the identification of 
genes whose expressions are correlated with each other. Genes with similar expression 
patterns are assumed to participate in common cellular pathways or functions, a concept termed 
“guilt by association” (75, 287). Computational algorithms can be used to identify interconnected 
genes and build gene networks. Gene correlation networks can be altered by LDR exposure, 
representing potential molecular pathways that mediate the radiation response (277).  
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Cumulating genotype data, expression data, and low dose radiation phenotype data may 
provide insights into LDR response, but the true power in a systems-genetic approach lies in the 
integration of these data together in a comprehensive fashion to reveal associations between 
DNA variation and LDR sensitivity and the molecular networks which drive those associations. 
Systems biology involves the integration of information through a hierarchy of networks 
beginning with genetic networks (genomics) that drive molecular networks (including RNA and 
protein expression networks) which are components of cellular networks that are interconnected 
to form tissue networks that define living systems (238). Complex phenotypes, such as low dose 
radiation responses, arise from the complex interactions of these networks.  
 
  
47 
 
CHAPTER III 
GENETIC ARCHITECTURE OF BXD IMMUNOPHENOTYPES 
This chapter is adapted from the following publication: 
Lynch RM, Naswa S, Rogers GL, Jr., Kania SA, Das S, Chesler EJ, Saxton AM, 
Langston MA, and Voy BH. Physiol Genomics 2010. 
 
The immune system plays a pivotal role in the susceptibility to and progression of a 
variety of diseases. Due to its strong genetic basis, heritable differences in immune function 
may contribute to differential disease susceptibility between individuals. Genetic reference 
populations, such as the BXD (C57BL/6J X DBA/2J) panel of recombinant inbred (RI) mouse 
strains, provide unique models through which to integrate baseline phenotypes in healthy 
individuals with heritable risk for disease because of the ability to combine data collected from 
these populations across both multiple studies and time. We performed basic 
immunophenotyping (e.g., percentage of circulating B and T lymphocytes and CD4+ and CD8+ T 
cell subpopulations) in peripheral blood of healthy mice from 41 BXD RI strains to define the 
immunophenotypic variation in this strain panel and to characterize the genetic architecture that 
underlies these traits. Significant QTL models that explained the majority (50 – 77%) of 
phenotypic variance were derived for each trait and for the T:B cell and CD4+:CD8+ ratios. 
Combining QTL mapping with spleen gene expression data uncovered two quantitative trait 
transcripts (QTTs), Ptprk and Acp1, as candidates for heritable differences in the relative 
abundance of helper and cytotoxic T cells. These data will be valuable in extracting genetic 
correlates of the immune system in the BXD panel. In addition, they will be a useful resource for 
prospective, phenotype-driven model selection to test hypotheses about differential disease or 
environmental susceptibility between individuals with baseline differences in the composition of 
the immune system.  
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Introduction 
Systems genetics takes a top-down approach to disease susceptibility by seeking to 
identify relationships between genetic variants, intermediate molecular, biochemical and cellular 
pathways, and overlying systems-level phenotypes from large-scale molecular and phenotypic 
analyses. Typically, putative interconnections are built through correlational analyses of diverse 
data types collected across genetically heterogeneous populations. These data are often 
obtained using genetic reference populations, i.e., populations that are genetically stable and 
thus reproducible, allowing data integration across time and from diverse studies and creating 
the possibility to uncover novel relationships among genes, pathways and diseases. A number 
of genetic reference populations exist for mouse, the largest of which is the BXD (C57BL/6J X 
DBA/2J) recombinant inbred (RI) strain panel, consisting of 81 extant strains for which genotype 
data are publicly available (207). As the depth of phenotyping for a reference panel like the BXD 
strain set increases, so does the ability to interconnect physiological systems through genetic 
correlation of phenotypes. Such discoveries can be valuable for determining the molecular basis 
for a phenotype, for identifying biomarkers for disease processes, and for elucidating 
interconnections between apparently divergent physiological systems.  
The burgeoning evidence that inflammation either initiates or fuels a wide variety of 
diseases and pathologies suggests that immune system components are likely to emerge in 
many systems-level networks of disease susceptibility. Disorders not traditionally linked with the 
immune system such as obesity and insulin resistance are now causally linked to inflammatory 
processes and mobilization of immune cells (100, 191, 283). While the abundance of specific 
lymphocyte subpopulations is altered by numerous environmental factors such as infection and 
diet (14, 261, 302), these traits are also under tight genetic control (3, 55, 125). The involvement 
of immune processes in myriad diseases, many of which have a genetic risk, coupled with a 
strong genetic basis for immune function, raises the possibility that genetic variation in immune 
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phenotypes per se may contribute to differential disease susceptibility between individuals. 
Supportive of this concept is a recent report by Dendrou et al., using the Cambridge 
BioResource, which is the human equivalent of a genetic reference population, consisting of 
~5,000 healthy, genotyped individuals living near Cambridge, UK who agreed to be studied 
repeatedly over time (67). Dendrou and colleagues linked a specific T cell phenotype – relative 
expression of CD25 on the surface of CD4+ memory T cells – with a haplotype previously shown 
to confer protection from type I diabetes. Understanding the genetic basis of specific 
immunophenotypes may therefore be valuable in understanding susceptibilities and/or 
progression of diseases, such as multiple sclerosis and rheumatoid arthritis, which are 
characterized by dysregulation or imbalances of distinct immune cell populations (59, 99, 240, 
253).  
As a first step toward determining the heritable differences in immunophenotypes that 
may predict outcomes of disease and environmental exposures, we profiled the abundance of 
major lymphocyte subpopulations (CD79+, CD3+, CD4+ and CD8+) in peripheral blood of 
healthy, unperturbed mice from the BXD strain panel. These data were integrated with existing 
genotype data in quantitative trait loci (QTL) mapping to characterize the genetic architecture 
that underlie these traits. They were further combined with microarray data we collected from 
spleens of the same strain panel to highlight potential candidate genes within significant QTL. 
Graph algorithms were used to identify gene expression networks that correlate with and are 
potential mediators of immunophenotypes, and are thus potential targets for environmental 
stimuli that act on the immune system. Herein we present evidence that peripheral 
immunophenotypes are under significant genetic control in the BXD population and describe 
genes and coexpression networks linking genetic variation to immunophenotypic diversity. 
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Methods 
Animals 
C57BL/6J, DBA/2J, and BXD RI stocks from strains 6 – 42 were obtained from The 
Jackson Laboratory (Bar Harbor, ME). BXD RI stocks from strains 43 – 100 were obtained from 
Dr. Lu Lu and Dr. Robert Williams from the University of Tennessee Health Science Center 
(UTHSC, Memphis, TN). BXD RI lines were housed and propagated in the specific-pathogen-
free (SPF) Russell Vivarium at Oak Ridge National Laboratory (ORNL). Mice received irradiated 
Purina Diet #5083 and chlorinated water ad libitum. The housing conditions were maintained at 
70 ± 2 °F and 40-60% humidity. A total of 45 BXD strains were used for spleen expression 
profiling, immunophenotyping, or both. This subset of the BXD panel was chosen from the set of 
strains maintained at ORNL based on consistent breeding performance and to represent a 
balanced combination of the original BXD strains developed at The Jackson Laboratory (259, 
260) and the advanced intercross strains developed at the UTHSC (207). Between 10-12 weeks 
of age, mice were sacrificed by cervical dislocation and either blood was collected for 
immunophenotyping or the spleens were harvested for RNA expression profiling. All studies 
were approved by the Animal Care & Use Committee at Oak Ridge National Laboratory. 
Immunophenotyping 
 Flow cytometry was used for the immunophenotyping of male and female mice 
(average of four mice/sex/strain) from 41 BXD strains and the parental strains. Blood was 
collected by retro-orbital sinus puncture into EDTA tubes and red blood cells were lysed using 
lysis buffer (Sigma-Aldrich, St. Louis, MO). Following centrifugation, the white blood cell pellet 
was suspended in buffer (PBS, 0.2% sodium azide, 0.02% heat-inactivated FBS) and divided 
into four aliquots for each set of monoclonal antibodies and a blank negative control. 
Lymphocytes were stained with the appropriate antibody or antibodies for 45 minutes at 4°C. 
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The negative control was incubated with PBS. One tube was dual-stained with anti-CD3 (PE, 
clone 17A2) and anti-CD79b (FITC, clone HM79b). Another tube was dual-stained with anti-
CD4 (PE, clone H129.19) and anti-CD8a (FITC, clone 53-6.7). The remaining tube was stained 
with anti-MHC Class II (R-PE, clone NIMR-4). Antibodies were purchased from BD Biosciences 
(Franklin Lakes, NJ), except MHC Class II-RPE which was purchased from Southern Biotech 
(Birmingham, AL). Following incubation, the samples were centrifuged and suspended in PBS. 
All samples were stored on ice in the dark until analyzed by flow cytometry. At least 10,000 cells 
per sample were analyzed using a Beckman Coulter Epics XL flow cytometer (Brea, CA). Data 
were analyzed using EXPO32 ADC Software (Beckman Coulter). Lymphocytes were gated for 
analysis based on forward and side scattering profiles. The immunophenotypes (IPs) measured 
included the proportion of circulating T cells (%CD3), B cells (%CD79), CD4+ T cells (%CD4), 
CD8+ T cells (%CD8), as well as the median expression of major histocompatibility complex II 
(MHCII Median) on MHCII+ lymphocytes (%MHCII). 
Identification of immunophenotype QTL  
Flow cytometric data were analyzed for quality based on efficient staining of 
lymphocytes and within-individual consistency (e.g., %CD79 approximately equaling %MHCII 
and sum of %CD4 plus %CD8 approximately equaling %CD3). Only high quality 
immunophenotype data were used for further analysis, resulting in an average of 3.3 males and 
3.2 females per strain for each IP. T cell to B cell ratio, CD4+ to CD8+ ratio, and MHCII median 
fluorescence were normalized using natural log transformation (i.e., LN T:B, LN CD4:CD8, LN 
MHCII).  
 QTL analysis was performed using genotype data obtained from GeneNetwork 
(http://www.genenetwork.org/dbdoc/BXDGeno.html). This database contains nearly 3,800 
informative single-nucleotide polymorphisms (SNPs) and microsatellite markers originally 
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reported by Shifman, et al. (235) that have been re-aligned with National Center for 
Biotechnology Information (NCBI) Build 36. QTL for each IP were identified using the QTL 
package (34) in R (http://www.r-project.org). The multiple imputation method of Sen and 
Churchill (230) was used to perform single-QTL genome-wide scans. Genome-wide significance 
thresholds were calculated based on 1,000 permutations (54). The cut-off p-values for 
significant and suggestive loci were P = 0.05 and P = 0.63, respectively (130).The ± 1 LOD 
support intervals for each QTL were calculated using the lodint function in R/QTL. Multiple-QTL 
modeling was performed using stepwise linear regression in SAS (SAS Institute, Cary, NC); a p-
value of 0.05 was used as the threshold for terms to remain in the final model.  
Expression profiling 
Transcriptome profiling was performed in spleens from an independent set of mice 
representing 38 BXD strains (34 of which were immunophenotyped). Total spleen RNA was 
isolated from spleens stabilized in RNAlater (Sigma-Aldrich) using RNeasy Mini Kits (Qiagen, 
Valencia, CA). RNA concentration and quality were assessed using Experion RNA StdSens 
Chips on the Experion system (Bio-Rad, Hercules, CA). Each BXD sample profiled consisted of 
a pool of equal amounts of RNA from either two males or two females per strain. Expression 
profiling was performed by Genome Quebec (Montreal, Canada) using the Mouse WG-6 v1.1 
BeadChip on the Illumina platform (San Diego, CA). Six strains were analyzed per chip. The 
data were normalized using Variance Stabilizing Transformation (VST) followed by Robust 
Spline Normalization (RSN) using the R/lumi package (74) in Bioconductor (87). Raw and 
normalized microarray data have been uploaded to NCBI‟s GEO database 
(http://www.ncbi.nlm.nih.gov/projects/geo; Accession GSE19935) according to MIAME 
standards (29). Expression data, along with all IP data, are also available through GeneNetwork 
(http://www.genenetwork.org).  
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Transcriptome Map and eQTL analysis 
Of the 34,492 probes on the Illumina arrays, 11,445 transcripts demonstrated variable 
expression across the panel (coefficient of variation > 0.01) and were used for expression QTL 
(eQTL) analysis. QTL Reaper (http://www.genenetwork.org/qtlreaper.html) was used to identify 
the maximum likelihood ratio statistic (LRS) and a permuted p-value (1,000 permutations) for 
each transcript. QTL Reaper performs Haley-Knott regression for QTL analysis, with an 
adaptive permutation by transcript which runs an increased number of permutations for those 
traits with significant results to ensure precise p-value estimation at the low end of the p-
distribution. This method is fast and sufficient for high density marker maps as are available for 
the BXD RI lines. At a p-value threshold of 0.05 over the entire array, 1881 transcripts were 
associated with 686 loci. These eQTLs were classified as cis or trans according to their genomic 
positions (located within or beyond 10Mb of transcription start site, respectively). Permutation 
testing was used to define the maximum number of transcripts likely to be associated by chance 
in trans with an eQTL. The 1881 transcripts were randomly assigned to the 686 significant loci; 
in 10 million permutations, the maximum number of transcripts associated in trans with a single 
marker was 19. Therefore we analyzed only the trans-eQTL bands in which a single marker was 
associated with 20 or more transcripts.  
Statistical modeling and graph algorithm 
 MGI (http://www.informatics.jax.org) was used to extract genes located within the ± 1 
LOD support intervals for the two significant QTLs identified for the CD4:CD8 
immunophenotype. Stepwise linear regression in SAS was used to model the CD4:CD8 ratio 
using the expression of these genes. Graph algorithms were performed as described previously 
(277), and all source codes are available from the authors. Graphs were created from 
microarray data by computing all pair-wise Pearson correlations between expressed transcripts 
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and then filtering the matrix to retain only statistically significant correlations based on a false 
discovery rate of 5% (q-value < 0.05; (250)). Maximal cliques were extracted and anchored 
cliques identified as previously described (277). A bipartite graph was created with one partition 
being the expressed transcripts and the second partition being a set of five immunophenotypes 
(CD3%, LN T:B, CD4%, CD8%, LN CD4:CD8). Pearson correlations were computed between 
each possible pairing of transcript expression and immunophenotype. Edges in the bipartite 
graph were filtered to retain correlations of interest (P < 0.001) and maximal bicliques were then 
extracted. Gene ontology (GO) enrichment analysis was performed using DAVID (102); 
Benjamini-Hochberg false discovery rate-corrected p-values are reported (19).  
Results 
We began by profiling a panel of immunophenotypes (IPs) in male and female C57BL/6J 
and DBA/2J mice to define baseline differences in the two BXD parental strains. Peripheral 
blood was analyzed for proportion of circulating T cells (CD3+), B cells (CD79+), T helper cells 
(CD4+), cytotoxic T cells (CD8+), and expression of major histocompatibility complex II (MHCII) 
on MHCII+ lymphocytes using flow cytometry. As shown in Table 3-1, the parental strains differ 
significantly in each of these traits (P < 0.05) except for CD3+ cells (P = 0.184) and CD8+ T cells 
(P = 0.064). C57BL/6J mice demonstrate a higher percentage of circulating B cells and CD8+ T 
cells and lower levels of CD4+ T cells compared with DBA/2J mice, which is consistent with 
previous reports (46, 186, 272). 
The same panel of immunophenotypes was profiled across a set of 41 BXD strains to 
establish the immunophenotypic diversity in this RI panel and to model the genetic regulation of 
each trait. ANOVA indicated a significant effect of strain on each IP (P < 0.0001), manifested as 
broad ranges for each of the traits across the strains. For example, the percentage of T 
lymphocytes varies over 5-fold (10.3 – 56.1%) while the percentages of CD4+ and CD8+  
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Table 3-1. Differences in peripheral blood immunophenotypes in C57BL/6J and DBA/2J 
mice.  
 
Immunophenotype C57BL/6J 
Mean 
DBA/2J 
Mean p-value 
% CD3 Lymphocytes 32.06 ± 1.03 35.60 ± 2.21 0.1840 
% CD79 Lymphocytes 61.40 ± 0.98 53.86 ± 2.73 0.0352* 
LN T:B -0.65 ± 0.03 -0.42 ± 0.09 0.0392* 
% CD4 Lymphocytes 23.84 ± 1.64 31.56 ± 2.41 0.0190* 
% CD8 Lymphocytes 7.98 ± 0.56 6.50 ± 0.47 0.0636 
LN CD4:CD8  1.10 ± 0.10 1.58 ± 0.07 0.0012† 
% MHCII Lymphocytes  61.62 ± 1.87 51.22 ± 2.64 0.0194* 
LN MHCII Density  3.53 ± 0.16 4.31 ± 0.08 0.0003† 
 
Data shown as mean ± SEM of 5 to 9 mice per strain. P-value indicates 
significance of strain effect (* P < 0.05, † P < 0.01). 
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lymphocytes vary over 6 fold (5.6 – 35.6% and 4.4 – 26.4%, respectively) (Fig. 3-1). These 
ranges relative to those of the parentals illustrate the genetic complexity of the traits and are 
within the range of the phenotypic diversity found in a survey of 32 standard inbred strains of 
diverse origin (22, 209). There is also a significant strain*sex interaction effect for each 
immunophenotype (P < 0.05), but the effect is much smaller (F statistic < 30%) than that of the 
main strain effects. Thus, overall strain effects were modeled for each immunophenotype.  
QTL analysis was performed on each IP as well as the T:B and CD4:CD8 ratios to 
identify overlapping and unique loci associated with each trait. We began with MHCII density as 
a reference trait with a defined genetic basis on Chromosome (Chr) 17, a region in which the 
BXD parental strains carry different haplotypes (C57BL/6J carries the H-2b haplotype and 
DBA/2J carries the H-2d). Not surprisingly, the genotype at the H2 locus is the largest factor in 
explaining median expression of MHCII on MHCII-expressing lymphocytes (Fig. 3-2A). The 
locus itself accounts for 57% of the variance within the BXD panel (LOD = 7.52, P < 0.001), with 
the DBA/2J genotype increasing MHCII expression. A suggestive secondary locus, Chr 10 @ 
114Mb, accounts for an additional 4.5% of the variance. The genetic basis for variation in the 
remaining immunophenotypes was modeled by first performing single model genome-wide 
scans (Fig. 3-2B,C) and then using suggestive and significant loci from those scans in multi-
locus regression to allow for additive and interactive contributions of multiple loci. A 9Mb region 
on Chr 17 spanning the H2 locus was identified as either suggestive or significant for single 
model scans of each trait except for the CD4:CD8 ratio (Fig. 3-3). The majority of variance (50.1 
– 77.5%) for each trait is explained by models incorporating the Chr 17 region in combination 
with at most three additional loci (Table 3-2). T and B cells were measured as a percentage of 
total gated lymphocytes and collectively represent the majority of this population, making these 
two measurements highly inversely correlated. Accordingly, the QTL models for each trait are 
very similar. The relative abundance between these two cell types (natural log transformed T:B  
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Figure 3-1. Peripheral blood lymphocyte subpopulations of BXD and 
parental strains. (A) %CD3 and %CD79 lymphocytes, (B) %CD4 and 
%CD8 lymphocytes, and (C) and MHCII density on MHCII+ lymphocytes 
(LN of median MHCII fluorescence). Data shown as mean ± SEM of at 
least 3 males and 3 females per strain. 
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Figure 3-2. Genome-wide scans for peripheral blood immunophenotypes of 
41 BXD strains. (A) MHCII density as measured by the LN of the median 
fluorescence of MHCII on MHCII+ lymphocytes, (B) T:B ratio as measured by the 
LN of the ratio of %CD3 to %CD79 lymphocytes. (C) CD4:CD8 as measured by 
the LN of the ratio of %CD4 to %CD8 lymphocytes. Solid horizontal lines 
represent genome-wide significance at P < 0.05, and the dashed lines represent 
P < 0.63, based on 1,000 permutations. LOD indicates logarithm of odds scores. 
 
59 
 
  
CD3
CD79
T:B* 
CD8
24
33
3
56
72
T:B
7
28
44
CD4:CD8* 
102
108
107
116
119
CD3
T:B
MHC
CD4
75
82
CD79
T:B
114
118
CD4
30
CD4:CD8* 
35
121
CD3
CD4
111
113T:B
40
31
CD3* 
CD79*
T:B*
CD4*
CD8, 
MHC*
10
11 12 13 17
Figure 3-3.  
 
Figure 3-3. Summary of BXD immunophenotype (IP) QTLs. The 
ranges indicate the ± 1 LOD support intervals for each significant and 
suggestive QTL, in Mb. Immunophenotypes are %CD3 lymphocytes 
(CD3), %CD79 lymphocytes (CD79), LN of CD3:CD79 (T:B), %CD4 
lymphocytes (CD4), %CD8 lymphocytes (CD8), LN of CD4:CD8 
(CD4:CD8), and LN of MHCII median expression on MHCII+ 
lymphocytes (MHC). * indicates significant QTL (P < .05) in single-
locus genome-wide scan. IP labels in black are QTLs that are 
significant in the final model (P < .05); gray IP labels are not significant 
in final model. 
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Table 3-2. Summary of final QTL models for BXD immunophenotypes. 
 
Immuno-
phenotype 
Final Model 
Variance 
Explained 
(%) 
QTLs 
  Marker Chr Position LOD 
%CD3 Loc1*2 + Loc2 58.9 Loc1 rs13477026 3 27 Mb 3.72* 
   Loc2 rs13482963 17 35 Mb 5.28* 
        
%CD79 Loc1 + Loc2 + Loc3 67.2 Loc1 rs13477026 3 27 Mb 4.17* 
   Loc2 rs13481119 11 79 Mb 2.54 
   Loc3 rs13482947 17 31 Mb 5.41* 
        
LN T:B Loc1*2 + Loc1*4 + 
Loc3+ Loc4 
77.5 Loc1 rs13477026 3 27 Mb 3.81 
  Loc2 rs13479274 7 58 Mb 2.64 
   Loc3 rs13481119 11 79 Mb 2.61 
   Loc4 rs13482947 17 31 Mb 5.62* 
        
%CD4 Loc1*2 + Loc3 50.1 Loc1 rs3690259 10 114 Mb 3.10 
   Loc2 rs3694890 12 118 Mb 2.70 
   Loc3 rs13482963 17 35 Mb 4.07* 
        
%CD8 Loc1*2 + Loc2 56.6 Loc1 rs13477030 3 28 Mb 3.82* 
   Loc2 rs3672987 17 33 Mb 3.79* 
        
LN 
CD4:CD8 Loc1 + Loc2 53.8 Loc1 rs13480570 10 31 Mb 
4.24* 
   Loc2 rs6225272 12 31 Mb 4.28* 
        
LN MHC 
Median Loc1 + Loc2 61.5 Loc1 rs3690259 10 114 Mb 
2.81 
   Loc2 rs13482947 17 31 Mb 7.52* 
 
 
Models were analyzed using significant and suggestive QTLs from single locus 
genome-wide scans. Representative SNP markers for each locus in the final models 
are reported; genome locations are according to NCBI Build 36. LOD indicates 
logarithm of odds scores based on single locus models. * indicates significant QTLs; all 
others are suggestive. 
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ratio, or LN T:B) was mapped to identify loci that may be involved in lymphocyte maturation.  
The T:B phenotype is partially explained by interactions between loci on Chrs 3 and 7 and 
between the Chr 3 locus and H2 locus. In combination with the additive effects of the H2 locus 
and an additional region on Chr 11, this model explains 77.5% of the variation in the T:B ratio. 
The only locus important in modeling the T:B ratio that was not identified for either lymphocyte 
population separately (i.e., %CD3 and %CD79) is the locus on Chr 7. The complete set of 
significant and suggestive QTLs for each immunophenotype is depicted in Fig. 3-3.  
Genetic control of T cell abundance was further probed by mapping loci that contribute 
to variance in the major T cell subpopulations, CD4+ and CD8+ T cells. While QTL analysis 
identified the H2 locus as contributing to both %CD4 and %CD8 (LOD of 4.07 and 3.79, 
respectively), the remaining QTLs were unique to the particular T cell subpopulations (Fig. 3-3). 
A multi-locus model consisting of three loci (on Chrs 10, 12, and the H2 locus) explains 50.1% 
of the variance in %CD4, while a model consisting of a locus on Chr 3 with the H2 locus 
explains 56.6% of the variance in %CD8. The ratio of CD4+ to CD8+ cells was used in QTL 
analysis after normalization using natural log transformation (LN CD4:CD8). Two loci (Chr 10 @ 
31Mb, LOD = 4.24 and Chr 12 @ 31Mb, LOD = 4.28) were identified as significant, independent 
contributors to this trait (Fig. 3-2C, Table 3-2). At both loci, the DBA/2J allele shifts the ratio in 
favor of CD4+ cells, consistent with the increased abundance of CD4+ cells in the DBA/2J 
parents (Table 3-1). These two loci explain nearly 54% of the variation in the CD4:CD8 ratio. 
Interestingly, neither region is implicated in control of either T cell subtype as analyzed 
independently, suggesting that these two regions contain genetic variation that contributes to a 
differentiation process in which one cell type is retained at the expense of the other. 
Expression QTL (eQTL) profiling has emerged as a means to identify loci linked directly 
or indirectly to regulation of gene expression (30, 71, 115, 226). We performed eQTL mapping 
using spleen microarray data to determine whether the QTL regions identified for IP traits also 
62 
 
harbored trans-eQTL bands, loci that are linked to expression of multiple genes and could thus 
be implicated in mechanistic control of the trait(s) through coordinated transcriptional regulation. 
Spleen was chosen because it contains abundant levels of both B and T lymphocytes and 
contributes to multiple aspects of immune function. Two trans-bands exceeded the maximal size 
of 18 transcripts obtained by permutation testing, consisting of 42 and 30 transcripts located on 
Chrs 4 (@ 139.0 Mb) and 12 (@ 15.8 Mb), respectively (Fig. 3-4). Neither trans-band co-
localized with IP QTLs, nor were the transcripts associated with each trans-band enriched for 
functions suggestive of IP regulation. Both bands did, however, contain an abundance of genes 
involved in cell cycle, cell division and DNA replication, which may have general relevance for 
heritable regulation of gene expression in the BXD panel. 
We further exploited the microarray data to identify potential IP candidate genes by 
determining if expression of one or more genes within the QTL intervals were correlated with the 
overlying trait(s), a strategy that has been used successfully for other traits (17, 152, 203). We 
identified quantitative trait transcripts (QTTs), transcripts whose expression is correlated with a 
phenotype (203), for the T:B and CD4:CD8 ratios. We focused on these two traits because they 
capture relative abundance of multiple cell types and have significant QTLs. Pearson‟s 
correlation coefficients were calculated between expression levels of genes residing within the ± 
1 LOD support intervals for each QTL and the immunophenotype data. Of the 517 genes 
located within these intervals for T:B ratio, 88 showed significant correlation with the phenotype 
(P < 0.05). GO enrichment analysis indicated that this set of genes was significantly enriched in 
processes related to antigen presentation and processing, as expected from the fact that many 
of these genes lie within the H2 locus on Chr 17. This set also contains a small number of 
genes (30 genes) that are highly correlated with T:B but reside on other chromosomes, the 
strongest of which are mitofusin 1 (r = 0.626, P < 0.0001) and phospholipase D1 (r = -0.563, P = 
0.0005), both of which are within the QTL on Chr 3. Mitofusins are mitochondrial fusion proteins  
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Figure 3-4.  
 
Figure 3-4. Spleen transcriptome map based on 38 BXD strains. The 
horizontal axis represents the genomic locations of the SNP markers/ QTL 
locations in Mb (chromosomes are in alternating colors), and the vertical axis 
represents the genomic location of each transcript in Mb. Each data point 
represents the maximum eQTL for each of the 1,881 transcripts that had a 
permuted p-value < 0.05.  
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that have recently been linked to the innate antiviral defense system (295). Phospholipase D1 
was shown to be critical for coordination of inflammatory signaling through TNF-alpha in 
leukocytes (231). 
Similar analysis of the QTL regions for the CD4:CD8 phenotype highlights a smaller set 
of potential candidate genes for this trait in the BXD panel. Of the 115 genes located within the 
QTL intervals for CD4:CD8 ratio, only 9 (7.8%) were significantly correlated with the CD4:CD8 
phenotype. Of these, the most highly correlated QTT (r = 0.575; P = 0.0004) is the transcript for 
protein tyrosine phosphatase, receptor type, K (Ptprk), a phosphatase expressed in spleen and 
other tissues (294) . Loss of Ptprk due to a spontaneous deletion in Long Evans Cinnamon 
(LEC) rats was recently shown to underlie the deficiency in CD4+ T cells in this model (124). 
Conversely, our data link increased expression of Ptprk with elevated levels of CD4+ cells. 
Stepwise linear regression of Ptprk and the eight other QTL interval genes correlated with the 
CD4:CD8 ratio was used to estimate the amount of trait variance explained by expression of 
these genes. A model containing Ptprk along with acid phosphatase 1 (Acp1; also known as low 
molecular weight protein tyrosine phosphatase) and laminin B-1 (Lamb1-1) explains 61% of 
variance in the CD4:CD8 phenotype (P < 0.0001). Like Ptprk, Acp1 is also a strong candidate 
gene for heritable variation in CD4:CD8 in the BXD panel. Polymorphisms in the human ACP1 
gene have been correlated with susceptibility to a number of inflammatory and autoimmune 
disorders such as type I diabetes, allergy and atherosclerosis, all disorders in which CD4 and/or 
CD8 cells are implicated in pathogenesis (20, 37, 162). Lamb1-1 has not been linked 
specifically to immune function but is widely expressed in spleen (154).  
Our group has developed a number of graph algorithms based on the extraction of 
cliques and other dense subgraphs to identify putative gene coexpression networks from large 
scale „omics data (16, 24, 47, 133, 277, 300). Here we use the concept of anchored clique to 
extract networks of genes co-expressed with Acp1 and Ptprk that may provide insight into the 
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mechanisms linking each gene to the CD4:CD8 phenotype. Both genes encode phosphatases 
and have been linked through genetic association studies to a number of inflammatory 
conditions, but relatively little is known about the cellular pathways in which each gene 
functions. The largest clique containing Acp1 in a graph thresholded at q-value = 0.05 (with 
corresponding P = 0.0026) consisted of a total of 500 transcripts. The correlations of genes 
within this clique range from |r| = 0.550 to 0.917. Gene Ontology enrichment revealed that this 
Acp1 coexpression network is highly enriched for genes involved in cell cycle (P = 2.0e-22, 
Benjamini = 1.1e-18), cell division (P = 1.6e-20, Benjamini = 4.2e-17), and DNA replication (P = 
2.4e-18, Benjamini = 3.2e-15). To insure that this high degree of GO enrichment was not 
somehow an artifact of our specific dataset, we identified genetic correlates of Acp1 expression 
in an independent spleen array dataset from 24 BXD strains within GeneNetwork (64). As with 
our data, Acp1 expression was highly significantly correlated with genes involved in cell cycle 
and related processes (e.g., GO term M phase, Benjamini = 1.13e-18). The cell cycle 
enrichment in our Acp1 anchored clique is also represented in the KEGG pathway for cell cycle 
control (P = 3.3e-12, Benjamini = 6.5e-10). Interestingly, of the 20 genes included in the KEGG 
pathway and co-expressed with Acp1, 18 are regulated by phosphorylation. These results 
suggest that abundance of the Acp1 transcript per se may regulate phosphorylation status of 
cell cycle targets, either directly or indirectly, in the spleen. Similar analysis was performed for 
the maximal anchored clique of 135 genes containing Ptprk, but significant GO enrichment was 
not observed. 
One of our long term interests is to identify gene coexpression networks linked to 
immune function in healthy individuals and to determine how these networks are perturbed by 
environmental factors that promote inflammation and/or alter immune function. To visualize the 
intersection between gene networks associated with IPs, we used a biclique algorithm to identify 
the largest set of transcripts in which each member is significantly correlated with each other 
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and one or more phenotypes. Pearson correlations were computed between each transcript and 
five immunophenotype measurements (%CD4, %CD3, LN T:B, %CD8, and LN CD4:CD8), and 
the matrix was thresholded to retain only those correlations most likely to symbolize true 
relationships (P < 0.001), leaving a total of 218 transcripts that are significantly correlated with 
one or more IPs. The relationship between gene expression and IPs are represented in Fig. 3.5, 
and as expected significant overlap exists between the sets of genes associated with each trait. 
For example, Notch4 is correlated with %CD3, LN T:B, %CD4, and %CD8. Notch4 is part of the 
highly conserved Notch family which play important roles in lymphocyte lineage commitment 
(256) and other cell-fate decisions (10). Specifically, there is evidence to support the role of 
Notch4 in the differentiation and expansion of hematopoietic stem cells and in 
lymphomogenesis (275, 296). These data provide a starting point from which to test the impact 
of specific environmental variables on networks of genes linked to IPs of interest. 
Discussion 
Systems genetics enables the detection of QTLs and the identification of putative 
candidate genes for further testing and validation. In parallel, it produces phenomic data that 
can be mined in the context of the system by integrating it with all of the other multi-scale and 
diverse data types obtained from the same population. At a total of 79 strains, the BXD RI strain 
panel is the largest inbred mouse RI panel, and one for which an abundance of genomic 
resources now exist (207). We characterized the range of variation and the genetic architecture 
of immunophenotypes in the BXD RI panel to produce a baseline profile of the immune system 
that can be integrated into systems genetics studies with this population. These data are 
relevant for genetic susceptibility to the plethora of environmental factors and disorders that 
invoke the immune system, e.g., ionizing radiation exposure and diet-induced obesity.  
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Figure 3-5. Bipartite graph demonstrating the 
connectivity of 5 immunophenotypes (IPs) and 
transcript expression. IPs are listed in the center of the 
graph and are symbolized by hexagons. The numbers of 
transcripts correlated (P < 0.001) with the IP(s) are 
depicted in the circles. The transcript sets symbolized by 
white circles create a maximal biclique with a single IP, 
while the transcript sets that create a maximal biclique with 
more than one IP are symbolized with gray circles. 
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 We found that genetic models explain the majority of variation in each of the 
immunophenotypes, which is consistent with reports from humans and other species that 
lymphocyte subpopulations in healthy individuals are under strong genetic control. Three of the 
immunophenotypes (proportions of B, CD4+ and CD8+ lymphocytes in peripheral blood) were 
previously profiled in 22 of the same BXD lines included in our study (46). Two of the three IPs 
are significantly correlated with our data (%B lymphocytes, r2 = 0.530, P = 0.010; %CD8 
lymphocytes, r2 = 0.437, P = 0.041) despite the passage of several years between studies and 
the use of independent BXD breeding colonies and institutions, highlighting the genetic stability 
of these phenotypes. The QTLs identified for these three traits differ between the two studies, 
likely because the Chen and Harrison (46) study relied on 35 BXD strains from the original BXD 
panel (strains 1 – 42) and a limited number of genetic markers, while ours was balanced 
between the original BXD set and the advanced recombinant inbred set produced by Peirce, et 
al. (207). Recent polymorphisms in this population (235) have been shown to influence the 
location and direction of QTL effects in these populations (210). In addition, a significant 
increase in the number of informative genetic markers are now available for the BXD panel and 
were used herein, which also may contribute to the discrepancy in QTL positions. Our reported 
QTL intervals (and those for many other traits mapped using the BXD panel) will likely be further 
refined with upcoming availability of genotype data across a panel of 580,000 SNPs, data that 
will soon be available through the GeneNetwork website (RW Williams, UTHSC, personal 
communication).  
Identifying QTLs is relatively straightforward and rapid when using genetic reference 
panels such as BXD for which genotype data are readily available; cloning the causative 
polymorphism and confirming its role in phenotypic determination is a much more elusive target 
and one that we have not attempted. However, by combining QTL mapping with gene 
expression data, we have winnowed the list of potential candidate genes for traits of interest to a 
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manageable number for further study. This approach produced two particularly compelling 
candidate genes – Ptprk and Acp1 – within the two significant QTLs associated with CD4:CD8, 
a trait used clinically as a marker for the prognosis of human immunodeficiency virus (HIV) 
(156), rheumatoid arthritis (81), and other diseases. Ptprk encodes a receptor-type protein-
tyrosine phosphatase with no specific properties that link it to lymphocyte development. 
However, a potential role for Ptprk in CD4+ T cell development was serendipitously uncovered in 
studies of the LEC rat, a model of Wilson‟s disease (due to a mutation in the copper transporting 
ATPase gene) that also had been noted to be deficient in CD4+ T cells (1). Recently, two groups 
(11, 124) used linkage analysis to identify a deletion containing Ptprk in LEC rats and confirmed 
that loss of Ptprk is responsible for defective CD4+ T cell development. Clinically, deletions of 
the chromosomal region containing PTPRK (chromosome 6q22-23) are frequently present in 
high-grade non-Hodgkin's lymphoma (188, 301), and loss of this region is also predictive of poor 
prognosis in CNS lymphoma (39), implicating this phosphatase in oncogenesis of the immune 
system. We used coexpression analysis in an attempt to gain insight into Ptprk function in 
spleen, based on the concept of genetic correlation. However, many of the transcripts with 
which Ptprk is most tightly co-expressed are un- or poorly- annotated, and no specific functions 
showed statistical enrichment. On the other hand, Acp1, the second candidate gene of interest 
for the CD4:CD8 phenotype, is part of a large clique of 500 transcripts that is highly enriched in 
functions related to cell cycle. Acp1, also known as low molecular weight protein tyrosine 
phosphatase, regulates phosphorylation status of a number of proliferative signaling molecules 
(244) and is up-regulated in several types of cancers (158, 163). Genetic screens in humans 
link polymorphisms in or near the ACP1 locus to a variety of inflammatory diseases including 
allergy, asthma and obesity (26), and Acp1 is involved in activation, adhesion, and 
differentiation of T cells (27, 88). The QTLs containing Acp1 and Ptprk reside on separate 
chromosomes that showed significant independent and additive linkage with the CD4:CD8 
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phenotype, suggesting that genes within each locus may interact to affect CD4:CD8 ratio. At the 
molecular level Ptprk positively regulates the protein tyrosine kinase Src (280), which in turn 
phosphorylates and activates Acp1 (36, 254). Whether these events occur in the same cell type, 
and in one relevant to T cell development, is unknown but is worthy of further experimentation. It 
is worth noting that both Acp1 and Ptprk have been linked through genetic screens to colon 
cancer susceptibility (245, 249). Germane to our overarching interest in radiation sensitivity is 
the fact that both Acp1 and Ptprk have been shown to be altered by radiation exposure (89, 
290).  
Although Ptprk and Acp1 emerge as attractive candidates for the CD4:CD8 phenotype, a 
potential limitation of our study is that the tissue (spleen) used to highlight these QTTs is not the 
site of T lymphocyte lineage commitment and selection, processes thought to primarily occur 
within the thymus (38). However, it has been suggested that there are compensatory 
adjustments that occur within peripheral immune organs (i.e., spleen and lymph nodes) and 
alters the T cell peripheral population (186). Therefore, it is possible that the expression levels 
of Ptprk and Acp1 in the thymus and spleen are regulated through similar mechanisms, or that 
the genetic polymorphisms that cause variation between strains exert similar effects in both 
tissues. If so, the relationship between trait values and expression levels would be predicted, 
even though the specific tissue profiled is not the primary tissue involved in the process of 
interest. Alternatively, the causative polymorphisms within the QTL intervals, whether in Ptprk 
and Acp1 or other genes or regulatory elements, may act on processes that occur in the 
periphery, such as T cell proliferation. However, the mice used in this study were not exposed to 
any known immune challenges and were maintained in an SPF facility, and we would expect 
peripheral proliferation of T cells to be minimal in these animals. It is also possible that, despite 
convergent evidence to support their contribution to CD4:CD8, the causative polymorphism for 
variation in this trait do not act through either Acp1 or Ptprk.  
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Genetic correlations between immunophenotypes in the BXD panel and disease 
susceptibility would be enriched by more detailed characterization of T cell subpopulations 
beyond the classification as either Th (CD4+) or Tc (CD8+). For example, additional surface 
markers could be used to further classify CD4+ cells as Th1, Th2, Th17, regulatory T (Treg), 
follicular helper T (Tfh), γδ T cells, etc. Each of these cell types play important roles in host 
defense and autoimmune diseases, and understanding the genetic basis of T cell subpopulation 
distributions would be invaluable in elucidating susceptibilities to T cell-mediated disorders, such 
as rheumatoid arthritis (123, 139, 291) .  
One of the advantages of using BXD strains as a reference population is the wealth of 
genotypic, phenotypic, and gene expression information available for the panel, much of which 
is freely available through the online database GeneNetwork. For example, we transiently 
uploaded our data into GeneNetwork to scan for genetic correlation between our 
immunophenotypes and other traits measured on the BXD population. This ad hoc analysis 
revealed an association between the baseline T:B ratio profiled in our study and outcomes of 
Chlamydia psittaci exposure as measured by Miyairi and colleagues (172). Among BXD strains 
that persisted 30 days post-infection, both spleen weight and pathogen load in spleen 
(GeneNetwork records 11025 and 11026) are significantly correlated (r = -0.811, P < 0.001, and 
r = -0.728, P = 0.003, respectively) with the T:B phenotype. The opportunity for such integrative 
analyses provided by the use of genetic reference populations such as the BXD panel highlights 
the strengths of systems genetics, namely the ability to assimilate genetic susceptibility to 
disease or the environment in the context of the healthy state through the stable genetic basis of 
the population. As the BXD strain continues to be phenotyped, the ability to connect seemingly 
disparate phenotypes grows proportionally. The Collaborative Cross, an idealized genetic 
reference population, should also be widely available within the next few years for expanded 
systems genetics studies (50). 
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In summary, we have characterized the genetic architecture of a set of basic but 
informative immunophenotypes in the BXD panel. We have uncovered potential candidate 
genes that contribute to genetic variation in the relative abundance of helper and cytotoxic T 
cells, and follow-on studies to test the roles of both Ptprk and Acp1 can now be initiated. 
Beyond the classical follow-ups to QTL mapping, these data can be a useful resource in 
choosing BXD strains with a particular baseline immunoprofile for the study of a particular 
disease susceptibility or progression. For example, we have gene expression data from spleen 
suggesting that low dose radiation exposure differentially impacts T cell subpopulations in a way 
that depends on genetic background (BH Voy et al., unpublished data). We can now use these 
BXD data to select strain subsets based on differences in T cell subpopulations and 
prospectively test if heritable differences in immunophenotypes alter radiation effects on 
immune function. 
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CHAPTER IV 
IDENTIFYING GENETIC DIFFERENCES UNDERLYING   
DIFFERENTIAL LOW DOSE RADIATION RESPONSES 
 
This manuscript will be submitted to Radiation Research with the following author list: 
Lynch RM, Naswa S, Rogers GL, Jr., Kania SA, Das S, Chesler EJ,  
Saxton AM, Langston MA, Bogard JS, and Voy BH 
 
The immune system illustrates the challenges of assigning risk to low dose radiation 
(LDR) exposure in a population. While high radiation doses clearly suppress immune function, a 
number of studies have shown that LDR affects immune cell subpopulations in ways that could 
be beneficial. In the intact organism, defining the consequences of LDR is further complicated 
by the impact of genetic background, particularly in systems such as the immune system for 
which both radiosensitivity and genetic effects are profound. We employed a systems genetics 
approach to test for heritable differences in LDR responses. Mice from 39 BXD recombinant 
inbred (RI) strains were exposed to 10cGy gamma radiation to determine effects on immune 
function and oxidative stress 48h after irradiation. LDR significantly enhanced neutrophil 
phagocytosis in a manner that was independent of genetic background. In contrast, genetic 
background significantly impacted LDR-induced changes in spleen superoxide dismutase 
activity. Transcriptome data from spleens of the BXD parental strains highlighted the impact of 
genetic background on LDR responses and also indicate that genetic variation in radiosensitivity 
is further unmasked at low radiation doses. Taken together, these data highlight the need to 
consider genetic variation when assessing LDR outcomes. 
74 
 
Introduction 
Average levels of radiation exposure over the past thirty years are estimated to have 
doubled, largely due to the widespread use of diagnostic imaging procedures such as computed 
tomography (190). Physically, the likelihood of an individual cell receiving a radiation track is 
proportional to dose, and the current model used to predict dose-dependent risk is based on 
linear extrapolation from high dose effects. Biologically, however, low doses of ionizing radiation 
elicit responses that are not necessarily observed at higher doses. A number of microarray 
studies have reported dose-specific gene expression profiles using mouse and human cell lines 
irradiated in vitro (6, 69, 83, 149, 237). Higher order phenotypes, such as reactive oxygen 
species (ROS) scavenging (292), DNA damage and repair (299), and immune responses (79), 
have also been shown to exhibit non-linear responses to increasing radiation dose (79). 
Therefore the physiological consequences of exposure to low doses of radiation (LDR, ≤10cGy) 
are not easily extrapolated from the responses characteristic of high dose radiation (HDR) 
exposure (79, 228, 262, 264).  
The immune system, which is known for its radiosensitivity, illustrates the challenges in 
delineating health effects of radiation exposure at low doses. High radiation doses (>1Gy) 
clearly suppress immune function through destruction of myeloid and lymphoid cell populations 
in bone marrow. In contrast, several studies of various immune cell types suggests that low 
doses of radiation enhances cellular functions that could be viewed as beneficial to the 
organism (143). For example, LDR has been shown to increase mitogen-induced lymphocyte 
proliferation (8, 111, 192, 201, 234), macrophage and natural killer cell activation (104, 147, 
194, 201, 233), and tumor surveillance (41, 98, 101, 122, 143, 194). At the molecular level, LDR 
alters gene expression (95), cytokine secretion (94, 104, 145), expression of surface molecules 
on immune cells (145, 146), and apoptosis (234), which can lead to LDR-induced modification 
of leukocyte distribution (96). Relatively little is known, however, about how this sensitivity 
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translates into efficacy of immune system, and if LDR alters the organism‟s ability to respond to 
invading pathogens.  
Classical studies of radiation sensitivity in mice illustrate the importance of considering 
genetic variation when ascribing biological consequences of radiation dose. In 1963, Roderick 
characterized survival times of 27 inbred mouse strains following daily exposure to 1Gy of x-ray 
radiation (high dose delivered at a high dose rate). The most susceptible strains, including 
CBA/J and BALB/cJ, succumbed to the radiation in approximately 16 days, while the most 
resistant strains, such as 129/J, survived more than twice as long. Since then, differences 
between strains at sublethal radiation doses have been reported for a number of outcomes, 
including radiation-induced apoptosis (178-181, 279) and carcinogenesis (157, 177, 266, 298). 
With respect to carcinogenesis, differences between strains have been described even though 
most are not inherently sensitive to radio-carcinogenesis. Given that genetic variation alters the 
effects of lethal doses, it is reasonable to suspect that evidence for radiation sensitivity would be 
even more apparent at low doses that present a more subtle challenge to cells and tissues. A 
limited number of studies have reported differential effects of low radiation doses in inbred 
mouse strains and in cell lines derived from a panel of human donors (117, 285).  
Incorporating genetic variation into models of environmental susceptibility in humans is 
challenging even for prevalent factors such as high fat diets or cigarette smoke. Population-
based mouse models, such as outbred crosses or recombinant inbred strain panels provide a 
means to address the impact of genetic variation on responses to environmental stimuli, such 
as radiation, for which large, controlled study populations or purposeful exposures are not 
available in humans. We describe the results of using BXD (C57BL/6J X DBA/2J) recombinant 
inbred (RI) mouse strains as a population-based model to assess the impact of genetic variation 
on response to LDR and to test the hypothesis that LDR alters aspects of immune function. The 
BXD recombinant inbred (RI) strain panel was used as a genetically characterized reference 
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population in which the parental strains (C57BL/6J and DBA/2J) exhibit known differences in 
baseline immune function and differential sensitivities and responses to LDR exposure (153, 
172, 281). Part of our overarching hypothesis is that the immunological effects of LDR exposure 
within a population depend in part on the individual‟s baseline immunoprofile and gene 
expression which are ultimately dependent upon genetic background. We utilize our previously 
published baseline peripheral blood immunophenotype and spleen expression data in the BXD 
panel to identify correlations with LDR responses. We focused our efforts on a limited number of 
biochemical and functional endpoints that could be efficiently assayed across a large number of 
mice. Transcriptomic profiling of spleen from the BXD parental strains was used to assess 
differential sensitivity to low dose radiation at the molecular level, and to test the hypothesis that 
genetic variation in the radiation response is more apparent at low doses. Here we show that 
LDR enhances neutrophil phagocytosis across the BXD panel, while spleen superoxide 
dismutase activity and spleen gene expression changes in response to LDR exposure vary 
significantly depending upon genetic background. 
Methods 
Radiation exposure 
C57BL/6J, DBA/2J, and BXD RI stocks from strains 6 – 42 were obtained from The 
Jackson Laboratory (Bar Harbor, ME). BXD RI stocks from strains 43 – 100 were obtained from 
Dr. Lu Lu and Dr. Robert Williams from the University of Tennessee Health Science Center 
(UTHSC, Memphis, TN). Mice were housed and propagated in the specific-pathogen-free (SPF) 
Russell Vivarium at Oak Ridge National Laboratory (ORNL) as previously described (153). 
Approximately 10 week-old mice from a balanced subset of 39 BXD strains selected from the 
original Jackson Laboratory strains (259, 260) and the advanced intercross strains developed at 
UTHSC (207) were exposed to a single dose of 10cGy radiation from a 137Cs source delivered 
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at a rate of ~9cGy/h. Each strain*treatment group consisted of an average of 4 irradiated or 4 
sham-exposed control mice per strain, and each group was balanced between males and 
females. Only 2 mice (1 irradiated and 1 sham control) per strain were exposed on any given 
day, and strains were randomized across the study. Following radiation or sham exposure, mice 
were housed for 48h in a satellite facility prior to dissection. Blood was collected by retro-orbital 
sinus puncture into heprinized tubes for neutrophil function assays. Spleens were harvested and 
snap-frozen in liquid nitrogen and stored at -80°C for subsequent biochemical assays.  
For spleen expression profiling, male C57BL/6J and DBA/2J mice were exposed to 
either a low dose (10cGy, as described above), or a high dose (1Gy) of γ-radiation delivered by 
a 60Co source with a dose rate of ~6Gy/min. Mice were sacrificed 24 following exposure, and 
spleens were stabilized in RNAlater (Sigma-Aldrich, St. Louis, MO) until RNA was extracted. All 
studies were approved by the Animal Care & Use Committee at Oak Ridge National Laboratory. 
Neutrophil functional assays 
Flow cytometry was used to assay neutrophil function in peripheral blood from 34 BXD 
strains 48h after sham or radiation exposure. For both assays, red blood cells in the blood 
samples were lysed and leukocytes were fixed prior to flow cytometric analysis. DNA staining 
was used to distinguish between aggregation artifacts and murine cells. At least 10,000 
leukocytes per sample were analyzed using a Beckman Coulter Epics XL flow cytometer and 
EXPO32 ADC Software (Beckman Coulter, Brea, CA). Neutrophils were gated for analysis 
based on forward and side scattering profiles. Gating based on fluorescence was set on 
unstimulated samples from each mouse to include approximately 10% of the evaluated cell 
population, and the same gating parameters were used to evaluate percentage and median 
channel fluorescence (MCF) of stimulated neutrophils exhibiting phagocytic or oxidative burst 
activity. Neutrophil phagocytosis (Phagotest Kit, Orpegen Pharma, Heidelberg, Germany) and 
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oxidative burst assays (Phagoburst Kit, Orpegen Pharma) were performed as previously 
described (135).  
Biochemical assays 
 Response to oxidative stress was assayed by quantification of superoxide dismutase 
(SOD) activity, glutathione (GSH), and oxidized glutathione (GSSG) in spleens from 39 BXD 
strains. Spleens were homogenized in 1mL of cold HEPES buffer (20mM HEPES, pH 7.2, with 
1mM EGTA, 210mM mannitol, and 70mM sucrose). The homogenate was aliquoted for SOD, 
GSH, and Bradford assays. SOD activity was measured in the spleen extracts using an 
enzymatic assay (Cayman Chemical Company, Ann Arbor, MI) that reflects the combined 
activity levels of all three SOD isoforms (SOD1, SOD2, and SOD3), normalized to the protein 
concentration of the spleen extract (Bio-Rad, Hercules, CA), and reported as the units of SOD 
activity per mg of protein (U/mg). The percentage of GSSG to total GSH in deproteinated spleen 
extracts was determined with a kit which utilizes an enzymatic recycling method using 
glutathione reductase (Cayman Chemical Company). GSSG levels were assayed separately 
from the determination of total GSH levels; both were assayed according to manufacturer‟s 
instructions using the end-point method. The percentage of GSSG to total GSH was 
determined, as well as the GSSG and total GSH concentration normalized to the protein 
concentration of the original spleen lysate. 
QTL mapping 
Quantitative trait loci (QTL) mapping was performed on SOD activity in sham and LDR-
exposed BXD mice. Estimates from the models described above were used for QTL mapping. 
QTL analysis was performed using nearly 3,8000 single-nucleotide polymorphisms (SNPs) and 
microsatellite markers for the BXD panel obtained from GeneNetwork database 
(http://www.genenetwork.org/dbdoc/BXDGeno.html). The genotype information was based on 
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the markers originally reported by Shifman et al. (235) which were re-aligned with National 
Center for Biotechnology Information (NCBI) Build 36. QTLs were identified using WebQTL (49), 
which creates a linkage map using a mixture mapping algorithm combining simple marker 
regression, linear interpolation, and standard Haley-Knott interval mapping. Genome-wide 
significance thresholds were calculated based on 1,000 permutations (54), and the cut-off p-
values for significant and suggestive loci were P = 0.05 and P = 0.63, respectively (130). 
Multiple-QTL modeling was performed using stepwise linear regression in SAS; a p-value of 
0.05 was used as the threshold for terms to remain in the final model. 
Parental gene expression profiling 
Transcriptome profiling in C57BL/6J and DBA/2J spleens was performed by Genome 
Quebec (Montreal, Canada) using the Mouse WG-6 v1.1 BeadChip on the Illumina platform 
(San Diego, CA). as previously described (153). Quantitative polymerase chain reaction (Q-
PCR) was used to confirm the microarray results of myeloperoxidase (Mpo) differential 
expression in the parental strains following radiation exposure. Reverse transcription was 
performed on 500ng of RNA using the Bio-Rad iScript cDNA Synthesis kit from Bio-Rad. 
QuantiTect primers were used in conjunction with the QuantiTect SYBR Green PCR kit 
(Qiagen) on a CFX96 real-time PCR detection system (Bio-Rad). All samples were analyzed in 
triplicate; Mpo expression was normalized to hypoxanthine guanine phosphoribosyl transferase 
(Hprt) expression. Fold changes were calculated based on the ΔΔCt method and differences 
between groups were tested using ANOVA. 
Statistical testing  
Statistical testing was performed using SAS (SAS Institute, Cary, NC). For biochemical 
and neutrophil function assays, Proc Mixed was used to test for strain, radiation, and 
strain*radiation interaction effects, using the assay date as a random variable. If the 
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strain*radiation term was not significant (P = 0.05), then a reduced model was rerun using only 
the strain and radiation terms. All neutrophil function and biochemical data reported are least 
squares means from the Proc Mixed model. 
Expression data from Illumina bead chips were normalized using Variance Stabilizing 
Transformation (VST) followed by Robust Spline Normalization (RSN) using the R/Bioconductor 
(87) package lumi (74). Fold changes were calculated after reverse transforming the data using 
inverseVST function of lumi package. Raw and normalized expression data are available 
through NCBI‟s GEO database (http://www.ncbi.nlm.nih.gov/projects/geo). SAS procedure GLM 
(General Linear Model) was used for analysis of variance (ANOVA) to test the effects of strain, 
dose and their interaction on expression (expression ~ strain + dose + strain*dose). Post 
ANOVA contrast tests were used to compare the groups C57BL/6J LD and C57BL/6J HD vs. 
C57BL/6J control, DBA/2J LD and DBA/2J HD vs. DBA/2J control, strain*LD interaction and 
strain*HD interaction. An alpha of 0.05 was used for all statistical tests. False discoveries due to 
multiple comparison testing were controlled by using q-value (250). Differential expression was 
considered significant if both p and q values were < 0.05 and fold change > 1.5. DAVID (68, 
102) was used for gene ontology (GO) enrichment analysis of differentially expressed genes. 
Benjamini-Hochberg false discovery rate-corrected p-values are reported (19).  
Results 
Neutrophil Function 
Across the panel of BXD strains, LDR exposure significantly increased both the 
percentage of phagocytic neutrophils (i.e., phagocytosis of one or more FITC-labeled bacteria 
per cell; P = 0.0437) and the median channel fluorescence (MCF) of phagocytic neutrophils, 
reflecting the number of bacteria phagocytosed per E.coli-positive cell (P = 0.0193, Fig. 4-1). 
The radiation effect translates into approximately a 4% increase in the number of cells   
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Figure 4-1. Effect of radiation on neutrophil function. Peripheral 
neutrophils were assayed using flow cytometry 48h after irradiation; N ≥ 
66 mice / group (A) A greater percentage of neutrophils from radiation-
exposed mice engulfed FITC-labeled E. coli compared to those of 
controls (p = 0.044). (B) E. coli-positive neutrophils from radiation-
exposed mice had a greater median channel fluorescence (Phagocytic 
MCF, indicating more bacteria engulfed per cell) compared to those of 
control (p = 0.019). Error bars reflect the SEM. 
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undergoing phagocytosis and an 11% increase in the number of bacteria engulfed by those 
cells, relative to sham controls. In addition to a main effect of radiation, both measures of 
phagocytic activity showed significant effects of strain (% Phagocytic Neutrophils, P < 0.001 and 
Phagocytic MCF, P = 0.0023), reflecting the impact of genetic variation on phagocytic function 
in the BXD panel. Despite the wide range of baseline variation across strains, there was no 
significant interaction between strain and radiation exposure (% Phagocytic Neutrophils, P = 
0.99 and Phagocytic MCF, P = 0.38). These results demonstrate for the first time using an in 
vivo model that low dose radiation alters neutrophil function. 
Flow cytometry also was used to measure the generation of intracellular reactive oxygen 
species (ROS) generated during oxidative burst. The percentage of oxidative burst-positive 
neutrophils (%OB Neutrophils) was analyzed as well as the MCF of positive neutrophils 
(measurement of enzymatic activity). While both %OB Neutrophils and OB MCF varied 
significantly by strain (P = 0.020 and P < 0.001, respectively), radiation and strain*radiation 
interaction effects were not significant (P = 0.66 and P = 0.54, respectively).  
Anti-oxidant defense system 
Total SOD activity in spleen varied significantly across the BXD strain panel (P < 0.001), 
reflecting the impact of genetic background on baseline SOD activity. Genetic background 
further altered the SOD response to LDR, as indicated by the very significant strain*radiation 
interaction (P < 0.001). Unlike for phagocytosis, the main effect of radiation was not significant 
(P = 0.32). Neither the GSSG levels nor percentage of oxidized (GSSG) to total glutathione 
(GSH) levels significantly differed among strains or between radiation and sham-exposed mice 
within strains (all P-values > 0.1). When total GSH levels were normalized to the protein 
concentration in the spleen lysate, a significant strain effect was observed (P = 0.0014), but 
there was no radiation main effect (P = 0.21) or strain*radiation interaction effect (P = 0.97).  
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The significant interactive effect of strain and radiation on SOD activity demonstrates 
that genetic factors play a pivotal role in the antioxidant response to low dose exposure. We 
performed QTL analysis to identify loci associated with this differential response to LDR, using 
genotype data readily available for the BXD panel (235). QTL analysis (Fig. 4-2) revealed a 
significant QTL on Chromosome (Chr) 15 (@ 74Mb, LOD = 3.54), as well two suggestive QTLs 
on Chr 16 (@ 69Mb, LOD = 2.34 and @ 93Mb, LOD = 2.80), that are linked to SOD activity in 
unexposed controls. The QTL on distal Chr 16 encompasses the Sod1 gene. In contrast, QTL 
analysis of LDR SOD activity identified a locus on Chr 17 (@ 76Mb, LOD = 1.17) which was not 
present in analyses of control SOD activity, suggesting that this locus mediates the SOD 
response to LDR but not baseline SOD activity. Further, the Chr 16 locus containing Sod1 was 
not present in the LDR QTL model. A multi-locus regression model which includes additive 
effects of the Chr 15, which were present in both models, and the Chr 17 loci explains 24% of 
the variance in SOD activity in the spleens of LDR-exposed mice.  
Correlations between baseline IP and gene expression with radiation outcomes 
The concept of genetic correlation (210) was applied to search for relationships between 
baseline traits in unexposed mice and low dose radiation responses, which may identify genes 
that are involved in or biomarkers of differential low dose response. Transcriptomic and 
immunophenotype data from spleens of an overlapping set of BXD strains were integrated with 
SOD activity and neutrophil function data, and all possible pair-wise Pearson correlations were 
computed between expressed transcripts, immunophenotypes and SOD activity in sham and 
LDR-exposed BXD strains. Spleen microarray data and immunophenotypes (e.g., CD79+, CD3+, 
CD4+ and CD8+ lymphocytes) in peripheral blood were collected as described previously (153). 
We were particularly interested in genes for which baseline expression levels were significantly 
correlated with post-radiation SOD activity but not with sham SOD activity. Interestingly, these   
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Figure 4-2. SOD activity QTL analysis. WebQTL interval mapping of spleen 
SOD activity in sham (A) and radiation-exposed (B) BXD mice. The mouse 
genome is portrayed along the horizontal axis, while the vertical axis shows the 
logarithm of odds (LOD). Significant and suggestive levels of association were 
determined based on permutation testing and are depicted by horizontal red 
and gray lines, respectively. Significant and suggestive loci are indicated by red 
and gray arrows, respectively. LOD scores are indicated by the blue line across 
the genome; the red line indicates that the C57BL/6J allele at the marker 
increases the SOD activity, while the green line indicates the DBA/2J allele 
increases activity. Strength of additive effects is indicated by the scale on the 
right. 
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parameters include expression of Sod2 which was significantly correlated with LDR SOD activity 
(r = 0.47, P = 0.0026) but not with sham SOD activity (r = 0.030, P = 0.86). In addition to Sod2, 
baseline expression of apoptosis-inducing factor, mitochondrion-associated 2 (Aifm2) was 
differentially correlated with LRD SOD activity (r = 0.55, P < 0.001) but not sham SOD activity (r 
= 0.16, P = 0.35). AIFM2 is a DNA-binding protein with oxidoreductase activity (161) and was 
originally described as a caspase-independent inducer of apoptosis (289), functions that have 
clear relevance to radiation response. With respect to immunophenotypes, we found a 
significant and inverse correlation between % Phagocytic Neutrophils and the CD4:CD8 ratio (r 
= -0.48, P = 0.0082, N = 29 strains) in LDR but not control mice which was largely due to an 
inverse correlation with the percentage of CD4+ lymphocytes (r = -0.33, P = 0.078) (Fig. 4-3).  
Spleen gene expression 
We used microarrays to compare and contrast effects of LDR in the two BXD parental 
strains based on differences in gene expression profiles. A higher dose (1Gy) exposure was 
included to determine if the effects of genetic variation, based on molecular phenotypes, were 
more apparent at a lower level of radiation exposure. Low dose radiation significantly altered the 
expression of 74 genes in both C57BL/6J and DBA/2J mice (q-value < 0.05 and fold change > 
1.5). This gene set is highly enriched in immune-related functions, including the Gene Ontology 
(GO) terms “response to wounding” (15 genes, Benjamini = 7.1E-8) and “defense response” (13 
genes, Benjamini = 2.9E-5). GO enrichment highlighted qualitative differences in the response 
of each strain. Genes differentially expressed in C57Bl/6J but not DBA/2J (N = 138) were 
significantly enriched in heme biosynthesis, while DBA/2J-specific LDR genes (N = 752) were 
enriched in various immune processes, including lymphocyte activation (Table 4-1). In total, 
1200 genes showed a significant strain*LDR interaction, reflecting genes for which the response 
to LDR depends upon genetic background. Consistent with previous reports of differential   
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Figure 4-3. Scatterplots of neutrophil phagocytosis of BXD mice with baseline 
immunophenotypes. Percent phagocytic neutrophils in low dose radiation-exposed mice 
(LDR) is significantly (P = 0.0082) correlated with the natural log of the CD4:CD8 ratio (LN 
CD4:CD8), which is largely due to the correlation with %CD4-positive lymphocytes (%CD4) 
and not %CD8-positive lymphocytes (%CD8). 
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Table 4-1. GO enrichment of genes demonstrating a LDR*Strain interaction. 
 
GO Biological Processa  
# of 
Genesb  Bonferroni  
hemopoietic or lymphoid organ development  44  4.21E-08  
M phase  41  1.18E-06  
DNA metabolic process  43  7.58E-04  
nucleosome organization  17  1.13E-04  
regulation of apoptosis  47  1.33E-02  
hemopoiesis  37  2.66E-06  
heme biosynthetic process†  8  1.32E-04  
B cell activation‡  14  4.57E-03  
T cell activation‡  16  1.87E-02  
antigen receptor-mediated signaling 
pathway‡  8  4.50E-02  
antigen processing and presentation of 
exogenous peptide antigen via MHC class II‡  
10  3.33E-06  
 
 
aSelection of enriched GO biological processes, level 5 
bNumber of genes with significant LDR*Strain interaction (q-value < 0.05) 
†Significant GO process unique to C57BL/6J low dose  
†Significant GO process unique to DBA/2J low dose  
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apoptotic responses in irradiated C57BL/6J and DBA/2J strains (44, 89), the list of significant 
LDR*strain interaction genes includes 50 genes involved in apoptosis regulation.  
The list of genes with the most significant LDR*strain interactions was further probed to 
identify specific cellular functions that manifested the strongest genetic differences in LDR 
response. After sorting the list based on q-value, 14 of the top 15 genes were found to be 
involved in varying aspects of neutrophil function (9, 35, 56, 58, 110, 114, 118, 137, 142, 159, 
255) (Table 4-2), all of which showed an inverse response to radiation between strains. Q-PCR 
was used to validate differential effects of LDR on Mpo, which confirmed significant down-
regulation in C57BL/6J (4.8-fold; P < 0.001) and up-regulation in DBA/2J (3.3-fold; P < 0.001). 
We used the text mining tool FABLE (http://fable.chop.edu) to query the entire LDR*strain 
interaction list for correlations with neutrophil function. A total of 157 genes were found in 10 or 
more PubMed articles relating to neutrophils, suggesting that LDR had differential effects on 
aspects of neutrophil function, depending upon genetic background.  
We compared the molecular responses to 10cGy (LDR) vs. 1Gy (high dose radiation, 
HDR) exposures in C57BL/6J and DBA/2J mice to determine if a more subtle environmental 
stimulus unmasked genetic variation that was less apparent with a higher dose. ANOVA 
identified a total of 562 genes differentially expressed in HDR mice, regardless of strain. As 
expected, this set of genes was significantly enriched in KEGG pathways for cell cycle (17 
genes, Benjamini = 2.4E-5), p53 signaling (10 genes, Benjamini = 7.3E-3), and DNA replication 
(7 genes, Benjamini = 0.011). Out of the 562 HDR and 964 LDR genes, 307 had altered 
expression in response to both radiation doses. This set of overlapping genes was significantly 
enriched in functions related to various biological processes including hemostasis (10 genes, 
Benjamini = 3.8E-04), chromatin assembly (8 genes, Benjamini = 0.0093), and immune system 
development (14 genes, Benjamini = 0.023). In contrast to LDR, in which a total of 1200 genes 
showed significant LDR*strain interaction, only five genes demonstrated differential HDR   
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Table 4-2. Top 15 genes demonstrating the most significant LDR*Strain interaction 
effects. 
 
Gene 
Symbol Gene Name q-valuea  
C57BL/6J  
Fold  
Changeb  
DBA/2J     
Fold  
Change  
     Prtn3 proteinase 3 1.7E-05  -14.9 12.2 
Ltb4r1 leukotriene B4 receptor 1 1.7E-05  -2.4 4.3 
Mpo myeloperoxidase  1.7E-05  -14.2 9.0 
Elane elastase, neutrophil expressed 1.7E-05  -12.8 9.8 
Tmem180 transmembrane protein 180 1.7E-05  -1.3 1.9 
Mt1 metallothionein 1 2.2E-05  -1.3 2.4 
Fcnb  ficolin B 2.2E-05  -3.9 5.0 
Cebpe CCAAT/enhancer binding protein (C/EBP), epsilon 3.5E-05  -3.3 4.6 
Mt2 metallothionein 2 3.8E-05  -1.2 2.9 
Camp cathelicidin antimicrobial peptide 4.9E-05  -9.0 5.9 
Ltf lactotransferrin 5.5E-05  -12.5 6.4 
Lcn2 lipocalin 2 7.2E-05  -8.3 7.6 
F5 coagulation factor V 7.2E-05  -1.7 1.9 
Pglyrp1 peptidoglycan recognition protein 1 7.2E-05  -1.5 3.6 
Chi3l1 chitinase 3-like 1 7.2E-05  -2.9 4.3 
          
 
 
aANOVA q-value for LDR*Strain interaction term  
bEstimated by reverse transformation of normalized microarray data  
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response between strains (q-value < 0.05 for interaction effect). These results suggest that 
while C57BL/6J and DBA respond to high dose radiation in a qualitatively similar manner at the 
level of gene expression, their responses diverge at a lower dose exposure.  
Discussion 
 We assessed the impact of LDR on the immune system by measuring the response of 
neutrophils to bacteria, a functional endpoint of the innate immune system. We demonstrated 
that across the BXD population, a single exposure to 10cGy of radiation significantly enhanced 
both the numbers of cells that engaged in phagocytosis and the phagocytic activity of those 
cells. These data suggest that, at least acutely, LDR increases the ability to respond to invading 
pathogens. Our findings are consistent with a study of immune function in residents of two 
villages in Iran, Taleshmahaleh and Chaparsar, who are exposed to background radiation levels 
13 times greater than normal due to elevated natural levels of radiation exposure. Residents of 
these two villages were shown to have increased neutrophil phagocytosis and motility, as well 
as differences in circulating cytokines such as IL-2, IL-4 and IL-10 (12). It is important to note, 
however, that both radiation quality and dose rate differ significantly between these two studies. 
One limitation of our study is that only one time point was analyzed (48 hours post-exposure), 
which was chosen to fit the overall study design characterizing LDR-effects that are downstream 
of the initial radiation stress. This time point may not be optimal for this phenotype; greater 
enhancement of phagocytosis might be observed at earlier or later time points following 
irradiation. Because the half-life of murine neutrophils in peripheral blood is approximately 8 
hours (150), the cells assayed by flow cytometry were irradiated while undergoing maturation in 
bone marrow. Therefore the mechanism of increased phagocytosis could include maturational 
effects on cells prior to their release into circulation. Alternatively, LDR may have increased 
phagocytosis by altering levels of cytokines and chemokines such as TNFα, IL-8, and IFNγ that 
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act on neutrophils in circulation (85, 94, 104). Phagocytosis is one of a series of steps that lead 
to bacterial killing, and only phagocytosis and oxidative burst (which was not affected by LDR) 
were measured in this study. Follow-up studies are necessary to more broadly define the 
functional effects of LDR on neutrophils. Our microarray data collected from the BXD parental 
strains further support significant effects of LDR on neutrophils, as indicated by the abundance 
of neutrophil-related genes with significant strain*radiation interaction effects (Table 4-2). 
Moreover, they suggest that these effects differ markedly between the two strains, as indicated 
by the inverse patterns of gene expression. Mature neutrophils were once thought to be 
transcriptionally inert, but are now known to respond to a number of stressors and cellular 
signals through changes in gene expression (rev. in (121)). We do not have parallel functional 
data in these two strains and thus cannot determine if phagocytosis was also differentially 
impacted by LDR in C57BL/6J and DBA/2J. Current efforts are directed to collecting these data 
and expanding the scope of LDR-induced neutrophil phenotypes, including chemotaxis and cell 
killing. We should also point out that the expression data were collected in spleen rather than in 
isolated neutrophils or in bone marrow, and divergent effects of LDR on gene expression could 
be due to indirect effects, such as differential neutrophil migration into spleen or clearance of 
apoptotic neutrophils. Further experiments will be necessary to test these hypotheses.  
In contrast to phagocytosis, SOD activity in response to LDR varied significantly 
between strains. SOD activity increases after radiation exposure to mitigate oxidative stress 
resulting from the radiolysis of intracellular water, a response that is largely due to increased 
activity of mitochondrial SOD (SOD2) (97, 199). We interpret the significant interaction between 
strain and treatment to reflect genetic differences in the kinetics of SOD activity and its repletion 
following radiation stress, as opposed to opposite regulation of the enzyme across strains. 
Increased SOD activity in spleen occurs within hours of LDR-exposure (292), but less is known 
about the persistence of the response over time. Our data indicate that certain individuals within 
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a population mount a more persistent antioxidant defense to LDR, or that the supply of SOD 
available is rapidly depleted in some individuals, while others have intrinsically greater response 
to oxidative LDR stress. The significant genetic correlation we observed between Sod2 
expression in spleen of unexposed mice and SOD activity after LDR exposure further supports 
this relationship. This relationship is consistent with results seen from genetically engineered 
Sod2 deficient mice, in which heterozygous C57BL/6J Sod2(+/-) mice have increased radiation 
sensitivity compared to wild type Sod2(+/+) controls (76). It would now be interesting to 
determine if BXD strains with the highest heritable levels of Sod2 expression are less 
susceptible to LDR responses that have been shown to be influenced by SOD2 activity, 
including adaptive radio-resistance and DNA damage (66).  
QTL mapping using existing resources for the BXD strain panel allowed us to identify a 
region on Chr 17 associated with LDR-induced but not control SOD activity. To our knowledge, 
this is the first identification of a QTL for differential responses to LDR. The gene encoding Sod2 
is located on Chr 17, but is positioned >60Mb downstream of the maximum LDR SOD activity 
QTL. Therefore it does not appear that genetic variation within the Sod2 locus itself, or in 
proximal regulatory regions, contributes to the LDR SOD variation between strains. In contrast, 
a QTL for control SOD activity encompassed the position of the Sod1 enzyme locus. Using 
previously collected microarray data from BXD spleens (153) we identified a gene, xanthine 
dehydrogenase (Xdh), that is located approximately 2Mb upstream of the maximum LOD, and 
has expression levels that are significantly correlated with LDR-induced but not sham control 
SOD activity (r = -0.34, P = 0.041 and r = -0.19, P = 0.26, respectively). XDH, along with 
xanthine oxidase, forms the xanthine oxidoreductase (XOD) system. XDH can be converted to 
the superoxide-generating enzyme xanthine oxidase (XO) by reversible sulfhydryl oxidation or 
irreversibly by proteolytic modification (248), a process that has been shown to occur in 
response to high (>3Gy) doses of ionizing radiation, potentiating tissue oxidative stress beyond 
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the initial radiochemical reactions (247). Whether variation in activity of the XOD system could 
potentially alter SOD activity upon radiation remains to be determined. Access to high density 
SNP-based genotypes, which will soon be available for the BXD panel, should allow us to 
narrow the QTL interval and facilitate the search for causal polymorphisms linked to differential 
SOD activity with LDR. 
Differences in radiation sensitivity between the BXD parental strains were first described 
by Roderick more than 45 years ago, with DBA/2J succumbing more quickly than C57BL/6J to a 
lethal dose of radiation (217). At more modest doses, C57BL/6J mice were shown to be more 
resistant to radiation-induced genomic instability than DBA/2J (193, 281, 288). Wright and 
colleagues described differential apoptotic responses between the two strains after 1Gy 
radiation, with C57BL/6J favoring apoptosis through rapid induction of p53 and up-regulation of 
pro-apoptotic Bax, and DBA/2J having a delayed but prolonged p53 activation with more 
emphasis on p21 activation and cell cycle arrest (57, 140, 279). Our microarray data collected 
from spleen further illustrates that genetic variation plays a major role in how these two strains 
respond to radiation, particularly at low doses. Based on the strain*radiation interaction term in 
the ANOVA model, 1200 genes showed evidence for response to LDR that depended upon 
genetic background. This set of genes is enriched for numerous GO terms, including aspects of 
cell maintenance and immune defense (Table 4-1). In general, genes altered by LDR in DBA/2J 
were more closely related to lymphocyte functions (e.g., B cell and T cell activation) than were 
genes responsive to LDR in C57BL/6J mice, which showed differential enrichment in processes 
related to erythropoiesis.  
How these distinct expression profiles manifest in differential immune consequences of 
LDR remains to be determined, but they do further confirm that genetic background plays a key 
role in LDR response. 
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In stark contrast to LDR exposure, only five genes showed a significant interaction 
between strain and radiation after a 1Gy exposure. These differential effects across a rather 
modest (10-fold) increase in dose suggest that above a certain threshold, the response to 
radiation between individuals qualitatively becomes more similar as the demand to abate 
damage overrides other less critical processes. As dose is lowered to a level that imposes 
oxidative stress rather than immediate damage, genetic variation in mechanisms for coping with 
stress and the consequential effects on other pathways begin to emerge. Our array data also 
support the concept that the mechanisms of LDR response are not simply a subset of those 
enlisted with higher radiation exposures. Only 32% (307 of 964 genes) of the genes differentially 
expressed following LDR-exposure were also changed in response to HDR. Taken together, 
these array data highlight the need to consider genetic variation when assessing LDR 
outcomes, perhaps even more so than for higher radiation doses. 
Using a genetically stable reference population for this study allowed us to go beyond 
QTL analysis and exploit genetic correlation as a means to identify other phenotypes correlated 
with, and potential functionally related to, LDR response. With respect to SOD activity, this 
enabled the discovery that Sod2 expression in the baseline, un-irradiated state is positively 
correlated with SOD activity after LDR exposure, using microarray data that we previously 
generated from spleens of BXD strains (153). Similar relationships between baseline gene 
expression and radiation sensitivity were reported by Amundson et al. using the National 
Cancer Institute Anticancer Drug Screen (NCI-60) panel of cell lines (5). In our case, Sod2 was 
an obvious candidate because of its known role in LDR adaptation, but nonetheless it was 
identified using a method that did not require a priori knowledge about what genes might be 
uncovered. Genetic correlation also uncovered a significant inverse relationship between 
neutrophil phagocytosis following LDR exposure and the CD4:CD8 lymphocyte ratio in un-
irradiated mice. Whether this relationship stems from a common regulator of T cell maturation 
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and radiation effects on phagocytosis or from an indirect association remains to be determined. 
Nonetheless, these relationships illustrate how systems genetics provides a framework for 
extracting interrelationships between phenotypes that might not otherwise be suspected. 
Mechanistically, this approach can uncover potential functional relationships that can be further 
tested, resulting in fundamental advances in physiology. At the translational level, systems 
genetics can potentially improve the assessment of risk through identification of phenotypes, 
whether they be molecular, cellular or biochemical, that signal differential sensitivity to radiation 
and other environmental challenges of concern.  
In summary, our results show both responses to low dose exposure that are robust to 
genetic variation (enhanced neutrophil phagocytosis) and those from which genetic background 
significantly impacts the response (SOD activity). By integrating these results with our previous 
analyses of BXD RI strains, we have demonstrated that heritable differences in baseline 
expression and immunophenotypes can correlate with various low dose radiation responses. 
These data provide the groundwork for predicting LDR responses using baseline expression, 
immunophenotypes, and/or genotype.  
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CHAPTER V 
FUTURE STUDIES 
 
This dissertation research has demonstrated that the BXD recombinant inbred (RI) strain 
panel is a powerful reference population for analyzing the effects of low dose radiation (LDR) on 
immune function. To our knowledge, this is the first report showing that neutrophil function can 
be enhanced following in vivo LDR exposure. Future studies will focus on further 
characterization of neutrophil function and the mechanisms behind the LDR induced stimulatory 
effects. While we have shown that phagocytosis of bacteria is enhanced following LDR, other 
important steps in neutrophil-mediated innate defense will need to be analyzed. For example, 
does LDR lead to an increase in bacterial recognition by the neutrophils? Are the stimulated 
neutrophils more efficient at bacteria killing once the bacteria are engulfed? Do chemokines 
such as IL-8 active neutrophils following LDR? Can a similar response be observed with an in 
vivo bacterial challenge? These questions need to be answered to have a better understanding 
of the mechanisms involved in LDR-modulated neutrophil function. It would also need to be 
determined if other general LDR responses, such as oxidative stress and the induction of 
apoptosis, are involved in the neutrophil response to exposure. Furthermore, our gene 
expression profiling highlighted the differential regulation of neutrophil-related genes between 
the two parental strains following LDR. On-going studies are determining if the expression of 
these same genes are altered in the bone marrow, the site of neutrophil maturation.  
By comparing LDR responses with baseline immunophenotype data, we found a 
negative correlation between neutrophil phagocytosis following LDR and the percentage of 
peripheral lymphocytes which are CD4+. Numerous studies have shown that CD4+ cells are 
particularly responsive/sensitive to LDR. It would be interesting to see if CD4+ cell counts or 
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gene expression is altered in a genetic-background dependent manner following LDR exposure, 
or if LDR alters the Th1/Th2 balance. 
Our analyses also suggested that baseline expression of mitochondrial SOD (Sod2) 
might be a predictor of SOD activity following radiation exposure. This possibility can be further 
explored by determining if the BXD strains with the highest Sod2 expression levels are more 
resistant to radiation-induced DNA damage. 
The results presented here, combined with previously published data, raise some 
interesting possibilities regarding the effects of low dose radiation exposure in humans. As 
mentioned above, there is concern over the risks associated with the dramatic increases in 
radiation exposure from medical diagnostic procedures. Because numerous animal studies 
have demonstrated that low doses of radiation can suppress harm from a subsequent larger 
radiation dose (“radiation conditioning hormesis”), it would very useful to determine similar 
responses can be observed in humans. A low dose radiation exposure, or “priming dose”, would 
be given prior to the larger radiation dose. Of course, in most cases, an individual does not 
know a priori when they will receive a significant radiation dose, but priming doses could 
possibly be administered prior to certain radiological medical procedures. For instance, would a 
“priming” chest x-ray administered prior to a CT or PET scan reduce long-term cancer risk? If 
so, the protective effect of the priming x-rays might be especially important for individuals who 
undergo multiple diagnostic scans. 
The data presented in this dissertation provide intriguing glimpses into the genetic basis 
of low dose radiation responses. These data provide the groundwork for developing 
personalized risk assessments of low dose radiation risk based on genetic background.  
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ASSESSING THE PULMONARY TOXICITY OF  
SINGLE-WALLED CARBON NANOHORNS 
    
This data was published in the journal Nanotoxicology in 2007. This research does not 
directly relate to low dose radiation biology, therefore it is presented in its entirety here instead 
of in the body of the dissertation. This study is the first study published, to our knowledge, 
assessing the potential toxicology of single-walled carbon nanohorns, and one of the first in vivo 
toxicology studies of carbon nanoparticles.  
This data is adapted from the following publication: 
Lynch R, Voy B, Glass D, Mahurin S, Zhao B, Hu H, Saxton A, Donnell R, Cheng M. 
Nanotoxicology. 1: 157-166, 2007.  
 
Abstract 
Previous studies have suggested that single-walled carbon nanotubes (SWCNTs) may 
pose a pulmonary hazard. We investigated the pulmonary toxicity of single-walled carbon 
nanohorns (SWCNHs), a relatively new carbon-based nanomaterial that is structurally similar to 
SWCNTs. Mice were exposed to 30 μg of surfactant-suspended SWCNHs or an equal volume 
of vehicle control by pharyngeal aspiration and sacrificed 24 hours or 7 days post-exposure. 
Total and differential cell counts and cytokine analysis of bronchoalveolar lavage fluid 
demonstrated a mild inflammatory response which was mitigated by day 7 post-exposure. 
Whole lung microarray analysis demonstrated that SWCNH-exposure did not lead to robust 
changes in gene expression. Finally, histological analysis showed no evidence of granuloma 
formation or fibrosis following SWCNH aspiration. These combined results suggest that 
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SWCNH is a relatively innocuous nanomaterial when delivered to mice in vivo using aspiration 
as a delivery mechanism. 
Introduction 
Burgeoning use of engineered nanoparticles and nanomaterials in commercial 
applications has raised concern about the potential health effects of both intentional and 
accidental exposures. Although exposure can occur by a variety of mechanisms, the inhalation 
route is of primary interest because of the ease with which particles of nanoscale dimensions 
become aerosolized (5). The lung is particularly susceptible to respirable toxicants because it 
has a large surface area which is in constant contact with the external environment (11). Unlike 
larger particles which are mainly deposited in the nasopharyngeal compartment, nano-sized 
particles can be deposited in the alveolar region of the lung with high efficiency (1). Once 
resident in the alveoli, nanoparticles may promote oxidative stress and trigger inflammation 
through proinflammatory cytokines released from epithelial cells and macrophages (12). If 
unchecked, persistent pulmonary inflammation may trigger fibrotic changes and loss of 
pulmonary function (23). 
While nanoparticles have been developed from an array of materials, carbon-based 
particles are at the center of the nanotechnology revolution (15). Most in vivo toxicity data for 
engineered carbon-based nanoparticles are from studies using single-walled carbon nanotubes 
(SWCNTs). Carbon nanotubes have unique physico-chemical, electrical, thermal, and 
mechanical properties which make them attractive for a variety of applications (3). Animal 
studies conducted with SWCNTs suggest that exposure to aggregates of SWCNTs induces 
pulmonary toxicity (16, 17, 21, 24). In each of these studies, rodents were exposed to a large 
bolus of nanotubes to mimic chronic inhalation exposure.  
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Although all of the studies reported that SWCNT-exposure induced the formation of 
granulomas and/or fibrosis, they disagreed on the presence or degree of pulmonary 
inflammation. These differences in these studies could be due to the preparation of the 
nanotubes (e.g., degree of purity or method of dispersion), the animal studied (e.g., mice or 
rats), the exposure method (e.g., intratracheal instillation or aspiration), dose, or even the 
agglomeration state of the SWCNTs. It is important to note that the results from previous 
SWCNT toxicity studies do not immediately imply the toxicity of other carbon-based 
nanoparticles. Indeed, it has been demonstrated that carbon-based nanoparticles exhibited 
differential cytotoxic effects to alveolar macrophages depending on the geometric arrangement 
of the carbon atoms (14). Surprisingly, SWCNTs were more cytotoxic than multi-walled carbon 
nanotubes (MWCNTs) and fullerene (C60). In addition, SWCNTs and MWCNTs were more 
cytotoxic than quartz (SiO2), a well-documented pulmonary hazard. Therefore, the potential 
toxicity of a nanomaterial cannot be inferred from its elemental composition alone.  
Here we investigated the pulmonary toxicity of single-walled carbon nanohorns 
(SWCNHs), a relatively new engineered carbon-based nanomaterial. Carbon nanohorns are of 
particular interest to hydrogen storage in energy (10) and fuel cell applications. In addition, 
SWCNH aggregates were studied as a carrier for the chemotherapy drug cisplatin (2).  
Individual carbon nanohorns are engineered as short (in length) horn-shaped tube 
structures, the tips of which are capped with five-membered carbon rings. Individual SWCNHs 
tend to self-aggregate into a larger structure approximately 80-100nm in diameter during 
formation, with the tips of individual nanohorns projecting outward from the center in all 
directions. Although individual SWCNH structure is similar to individual carbon nanotubes, the 
former may find interesting and large-scale applications earlier than SWCNTs. For example, 
SWCNHs can be produced through laser ablation of a pure carbon target without the use of 
transition metal catalysts. This is of particular relevance for toxicity studies because metal 
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contaminants themselves could provoke inflammatory responses and oxidative stress. Although 
SWCNTs can be acid-washed to remove the majority of the catalysts, the residual metals can 
still contribute to the inflammatory response (17) making it difficult to assess the toxicity of 
SWCNTs. In a recent in vitro cell line based study, amino-modified SWCNH aggregates were 
shown be taken up by mammalian cells but caused little cytotoxicity (13). At the time of this 
writing, however, we are not aware of any published studies documenting the in vivo toxicity of 
SWCNHs.  
Our primary objective in this study was to characterize the pulmonary response of 
SWCNHs and compare the results to published SWCNT data. Keep in mind SWCNTs can be 
completely different from SWCNHs in eliciting biological responses and the comparison was 
made with care. We were not intending to establish a dose-response relationship of SWCNHs 
nor were we interested in dose rate of this new nanomaterial in this research. Thus, a single 
dose was chosen for this exploratory toxicity study. Each mouse in this study was exposed to 30 
µg of surfactant-suspended SWCNHs or to an equal volume of vehicle control by pharyngeal 
aspiration. To assess the pulmonary inflammatory response, the accumulation of cytokines and 
chemokines, total cell counts, and differential cell counts in bronchoalveolar lavage (BAL) fluid 
were measured. Oxidative stress was estimated by the reduction of glutathione (GSH) in lung 
tissue. Gene expression profiling by microarray analysis was used as an unbiased estimator of 
overall changes within the whole lung in response to SWCNH exposure. The ability of SWCNHs 
to induce granuloma formation and/or fibrosis was evaluated by histological examination of lung 
tissue following the exposure.  
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Methods 
SWCNH preparation and exposure 
Single-walled carbon nanohorns (SWCNHs) were synthesized using laser ablation of a 
pure carbon source as previously described (8). The detailed characterization of SWCNHs and 
their formation could also be found in Cheng et al. (2007). In order to expose the mice to a 
homogenous suspension of nanoparticles, SWCNHs were solubilized in phosphate buffered 
saline (PBS) using the nonionic surfactant Pluronic F-127 (Molecular Probes), which is 
biocompatible. A 1 mg mL-1 solution of SWCNHs suspended in PBS with 1% Pluronic was used 
for nanoparticle aspiration; 1% Pluronic in PBS was used for vehicle exposure. The SWCNH 
suspension was sonicated for 5 minutes just prior to aspiration. 
Male C57BL6/J mice were obtained from The Jackson Laboratory (Bar Harbor, ME). The 
mice were housed in a specific pathogen-free vivarium maintained at Oak Ridge National 
Laboratory (ORNL) and were acclimated to this facility for at least two weeks before use. All 
experiments were performed under an approved ORNL Animal Care and Use Committee 
protocol. Mice were exposed to 30 μg of SWCNHs or an equal volume of vehicle control 
(surfactant/PBS only) via pharyngeal aspiration. Aspriation is a minimally invasive technique 
that effectively delivers particles to the alveolar region of the lung with even distribution (20) and 
has been used in previous nanotoxicology studies to assess the pulmonary response to 
SWCNTs (17, 21). The mouse was anesthetized using isoflurane in a bell jar and once it 
reached the appropriate anesthetic plane, it was suspended by its front incisors on a thin wire 
attached to an inclined board. The tongue was extended with blunt forceps and the fluid was 
placed on the back of the tongue and aspirated into the lungs upon inspiration. When there was 
no more fluid within the mouth cavity, the tongue was released.  
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Bronchoalveolar Lavage 
Mice were sacrificed 24 hours or 7 days after aspiration by an overdose of isoflurane 
followed by exsanguination. Bronchoalveolar lavage (BAL) was performed as previously 
described (21) with minor modifications. A blunt 22-gauge needle was inserted into the trachea 
and secured with suture material. BAL was performed three times with cold, sterile Ca+2 and 
Mg+2 – free PBS. For the first lavage, 0.6 mL of PBS was used, and the recovered fluid was kept 
separate from subsequent lavages for cytokine analysis. Two additional lavages were 
performed with1.0 mL of PBS each and pooled together. After centrifugation at 4°C, the BAL 
cellular pellet was resuspended in cold PBS for total and differential cell counts. A 
hemocytometer was used to determine the total number of cells in the BAL fluid. Differential cell 
counts were performed on cytospin slides stained with a Hema-3 kit (Fisher Scientific). A 
minimum of 200 cells per slide were counted. The supernatant from the first lavage was stored 
at -80°C until analyzed. Cytokine and chemokine analysis of BAL samples was performed by 
Linco Diagnostics. The full panel of mouse cytokines and chemokines, a total of 22 analytes, 
were measured.  
Oxidative Stress 
As a biomarker of oxidative stress, lung glutathione (GSH) levels were quantified on 
samples obtained from mice 24 hours after aspiration using a Glutathione Assay Kit (Cayman 
Chemical). Post-lavaged lungs were homogenized, deproteinated, stored at -20°C, and assayed 
according to the manufacturer‟s instructions. This assay utilizes an enzymatic recycling method 
for the quantification of total glutathione or oxidized glutathione (GSSG) levels. The production 
of the product was monitored using the absorbance at 405 nm. The total glutathione and GSSG 
levels were determined in separate assays. Each sample was performed in duplicate. The 
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concentrations of GSSG and total GSH were calculated based on appropriate standard curves 
of known concentrations. 
Histology 
For histological analysis, vehicle and SWCNH-exposed mice were sacrificed 7 days after 
exposure by isoflurane overdose in a bell jar followed by exsanguination, and lung fixation was 
performed using standard protocols. The trachea was cannulated as described above, and the 
lungs were fixed with 10% neutral buffered formalin suspended 20 cm above the work surface 
to allow the lungs to fill through the cannulated trachea. The flow of formalin was stopped when 
the lungs were fully inflated with fixative. The trachea was sealed off with sutures, and the 
trachea, lungs, and heart were removed and submerged in additional formalin. After 24 hours, 
the tissues were switched to 70% ethanol for gross trimming and sectioning. Thin sections were 
stained with haematoxylin and eosin.  
Gene Expression Profiling 
For analysis of lung RNA expression, 3 vehicle and 3 SWCNH-exposed mice were 
euthanized by cervical dislocation 24 hours after aspiration. The lungs were immediately 
extracted and submerged in RNAlater (Ambion) and stored at 4°C until processed. Total RNA 
was isolated from homogenized lungs using an RNeasy kit (QIAGEN) according to the 
manufacturer‟s protocols. RNA samples were shipped to the Microarray Core Facility at 
Washington University for analysis. RNA quality and concentration was analyzed using the 
Agilent Bioanalyzer. Gene expression profiling was performed using the Mouse-6 Expression 
BeadChip (Illumina). Differentially expressed genes were identified using mixed model analysis 
of variance (ANOVA) implemented in Statistical Analysis Software (SAS Institute, Inc.) (25), and 
controlling the false discovery rate at 5% using QVALUE software (22) implemented in the 
statistical language R (bioconductor.org).  
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Electron microscopy  
A high resolution transmission electron microscope (HR-TEM; Hitachi HF-2000) was 
used to confirm the morphology and size of the SWCNHs as previously described by Cheng et 
al. (2007). Scanning electron microscopy (SEM) analysis was performed to assess the 
morphology of BAL macrophages after SWCNH exposure. SEM analysis was performed on 
BAL cells harvested from SWCNH and vehicle-exposed mice 24 hours after aspiration. Lavage 
cells were isolated using the BAL procedure described above, except all lavages from each 
animal were pooled together and a total of 4.6 mL of PBS was used in order to maximize the 
total cell yield. The BAL cells were centrifuged at 4°C and resuspended in warmed Dulbecco's 
Modified Eagle's Medium supplemented with 10% fetal bovine serum (InvitrogenTM). Cells were 
seeded on 12 mm glass coverslips in 12-well tissue culture plates and incubated at 37°C and 
5% CO2 for one hour to adhere. The media and non-adherent cells were aspirated off, and the 
cells were fixed in 3% gluteraldehyde (Sigma ®) in 0.1M phosphate buffer (pH 7.4) for 1 hour at 
room temperature. Samples were rinsed in phosphate buffer 3 times for 10 minutes each and 
then post-fixed in 2% osmium tetraoxide in 0.1M phosphate buffer for 1 hour at room 
temperature. The samples were dehydrated in a graded ethanol series and critical-point dried 
with CO2. Samples were sputter-coated with a thin layer of gold for imaging. 
Results 
As shown in Fig. A-1A, individual SWCNH aggregate structures were approximately 80-
100nm in diameter with horn-like projections, consistent with that reported earlier (8). To 
facilitate a homogenous particle suspension for exposures, SWCNHs were suspended in PBS 
with 1% Pluronic and sonicated prior to aspiration.  
SWCNH-exposed mice exhibited no overt clinical symptoms of distress from the time of 
anesthesia recovery until the time of sacrifice 24 hours or 7 days post-exposure. Lungs of  
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Figure A-1. Single-walled carbon nanohorn (SWCNH) exposures. (A) TEM image of 
an aggregate of SWCNHs containing individual cone-shaped SWCNHs in a spherical 
orientation. The arrow indicates a single SWCNH projecting from the aggregate. Image 
reproduced with permission of Nanotechnology (IOP Publishing Limited, Cheng et al. 
2007). (B) Dorsal view of formalin-filled lungs from SWCNH (left) and sham-exposed 
(right) mice 7d after aspiration. Cytospin preparations of BAL cells from sham (C) and 
SWCNH-exposed (D) mice 24h after aspiration. The arrow points to one of the multiple 
aggregates of SWCNHs. (E) SEM image of a BAL cell from a SWCNH-exposed mouse 
24h after exposure. Note the large aggregate of SWNCH adjacent to the cell indicated 
by the arrow. 
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SWCNH-exposed mice were slightly darker in color than were those from vehicle-exposed 
controls 7 days post-exposure (Fig. A-1B), indicating that the nanoparticles were well distributed 
through the lung and that complete clearance of SWCNHs had not occurred. BAL fluid was 
examined for increases in total cell count as a general assessment of neutrophil and 
macrophage recruitment in an inflammatory response to SWCNHs. Total number of cells in BAL 
fluid did not differ between SWCNH and vehicle-exposed mice 24 hours or 7 days post-
exposure. Consistent with these results, neutrophils were rarely observed in BAL fluid from 
SWCNH-exposed mice, and macrophage numbers did not significantly differ between the two 
exposure groups. Visible differences in macrophages were, however, observed. Carbonaceous 
material was clearly visible as dark aggregates within the cytoplasm of alveolar macrophages in 
SWCNH-exposed mice (Fig. A-1D) but was not present in samples obtained from vehicle-
exposed mice (Fig. A-1C). Although the SWCNHs were coated with surfactant and delivered as 
a suspension of particles in the 100 nm size range, their visibility with light microscopy in 
macrophage cytoplasm suggests the presence of larger aggregates within the cell. Whether 
formation of larger aggregates occurred before or after phagocytosis by macrophages cannot 
be determined from these samples. As shown in Fig. A-1E, large aggregates of SWCNHs near 
or on the surface of lavage cells were detected in samples obtained from mice 24 hours post-
exposure.  
To investigate the pulmonary cellular response to SWCNH exposure, the concentration 
of 22 cytokines and chemokines in the acellular BAL fluid was measured to assess early (24 
hours post-exposure) and sustained (7 days) inflammatory responses. Seventeen of the 22 
analytes were not significantly different between control and nanoparticle-exposed mice at 
either time point: IFN-γ, IL-10, IL-12, IL-13, IL-15, IL-17, IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-7, IL-9, 
MCP-1, MIP-1α, RANTES, and TNF-α. Five analytes were statistically different between 
exposure groups (α = .05) (see Fig. A-2). Granulocyte macrophage colony-stimulating factor  
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Figure A-2. Cytokine accumulation in BAL fluid 24h and 7d after aspiration of 
SWNCH solution or vehicle. (A) GM-CSF, (B) G-CSF, (C) IP-10, (D) IL-5, (E) KC. 
Results are the mean ± SE of duplicate measurement (n = 4 mice / group). Compared 
with sham-exposed mice, * P<.05. 
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(GM-CSF), granulocyte colony-stimulating factor (G-CSF), interferon-inducible protein-10 (IP-
10), and interleukin-5 (IL-5) were significantly elevated in BAL fluid from SWCNH-exposed mice 
compared to the vehicle-exposed mice 24 hours after aspiration (Fig. A-2A-D). These 
differences did not persist at 7 days, at which time there were no significant differences in GM-
CSF, G-CSF, IL-5 and IP-10 concentrations between SWCNH and vehicle-exposed mice. Only 
one cytokine, the neutrophil chemoattractant KC, was significantly higher in SWCNH-exposed 
mice at both 24 hours and 7 days after aspiration (Fig. A-2E). These results suggest an early 
but mild inflammatory response which is primarily resolved by 7 days post-exposure. The 
responses might be different (e.g., enhanced), if the mice were predisposed with allergic genes.  
In addition to inducing inflammation, various nanoparticles can trigger oxidative stress 
after uptake into cells (6, 19). The ratio of oxidized to total glutathione (GSSG:GSH) in lung 
homogenates was used to assess the overall pulmonary anti-oxidative balance after SWCNH 
exposure. The GSSG:GSH ratio was not different between the two experimental groups 
(vehicle-exposed ratio = 0.298 + 0.043; SWCNH-exposed ratio = 0.292 + 0.034), indicating that 
the presence of SWCNH particles within pulmonary macrophages did not promote a 
generalized oxidative stress within the lung.  
While BAL fluid data presented in Fig. A-2 indicate a mild but significant acute increase 
in inflammation, the response of the lung itself determines the long-term effect on pulmonary 
function. Global gene expression profiling was used to detect potential SWCNH-induced 
changes in the lung in an unbiased and comprehensive manner, and to identify molecular 
events that could signal activation of response pathways not captured by cytokine/chemokine 
assays or by assay of oxidative stress.  
Total RNA extracted from both lungs of the vehicle and SWCNH-exposed mice was 
used to profile relative expression levels of approximately 46,000 mRNAs (n = 3 / group). While 
some transcripts showed a treatment-related trend for altered expression levels, no statistically 
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significant differences in expression were identified when using statistical procedures to control 
for multiple testing. These results are consistent with the mild inflammatory changes in BAL fluid 
and with the lack of indication of oxidative stress in lung.  
Histological analysis was used to determine if SWCNHs resulted in pulmonary structural 
changes that could be suggestive of inflammation or early fibrosis development, as has been 
reported for SWCNT exposure in rodents (16, 21, 24). Lung sections from four SWCNH and 
four vehicle-exposed mice were analyzed by microscopic examination. There were no signs of 
granulomas or early fibrosis in either group. No other indicators of inflammation (increased 
neutrophils, lymphocytes, plasma cells, vascular dilation, or fibrin accumulation) were observed. 
The only discernible difference between the two groups was the presence of carbonaceous 
material within the cytoplasm of intra-alveolar and septal macrophages in the SWCNH-exposed 
lungs (Fig. 3), consistent with the presence of carbon in BAL macrophages (Fig. 1D).  
Discussion 
As research and development of engineered carbon-based nanomaterials races forward, 
it is expected that the risk of intentional and unintentional pulmonary exposure will increase. 
Recent animal studies have shown that carbon nanotubes, a cousin of carbon nanohorns, can 
cause pulmonary inflammation and/or lung tissue damage with granuloma formation and fibrosis 
(16, 17, 21, 24). Because engineered carbon nanoparticles of different geometries have shown 
differential toxicity in vitro (14), we investigated whether exposure to SWCNHs could lead to 
similar lung inflammation as SWCNTs did in rodents. Mice were exposed to SWCNHs in 
suspension using pharyngeal aspiration. Using the same technique, Shvedova et al. (2005) 
exposed mice to 0, 10, 20, or 40 μg of SWCNTs. This range was chosen to be comparable to 
occupationally relevant exposures. They had determined that a 20 μg dose of SWCNTs per 
mouse was equivalent to 20 8-hour workdays of exposure to graphite particles at the USA  
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Figure A-3 SWCNH in lungs of exposed mice. Thin lung sections from a sham (A) 
and SWCNH-exposed (B) mice 7d after aspiration. Carbonaceous material is visible 
within alveolar macrophages (arrow heads in B). (C) and (D) higher resolution images of 
images A and B, respectively. Carbonaceous material is clearly visible within the 
alveolar macrophages of SWCNH-exposed mice (D). 
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Occupational Safety and Health Administration (OSHA) permissible exposure limit. In our study, 
mice were exposed to a comparable amount (30 μg) of SWCNHs.  
We found evidence of mild but significant acute pulmonary inflammation in response to 
SWCNH exposure, indicated by increased levels of GM-CSF, G-CSF, IP-10, IL-5 and KC in 
BAL fluid 24 hours post-exposure. Levels of all but one chemokine (KC) were no longer 
statistically different from vehicle-exposed controls at 7 days post-exposure, suggesting a 
transient response. Both KC and IP-10 act as neutrophil chemoattractants by recruiting 
neutrophils to sites of inflammation and tissue damage. However, despite these increases, no 
evidence was found of neutrophil recruitment into the lung following exposure. This could be 
due to the relatively modest induction of KC and IP-10 levels. Of the cytokines that were 
increased at 24 hours post-exposure, only GM-CSF has been implicated in the formation of  
fibrosis (26). Other cytokines known to pro-fibrotic, such as interleukin-1β (IL-1β), tumor 
necrosis factor-α (TNF-α), and transforming growth factor-β1 (TGF-β1) were not significantly 
elevated in SWCNH-exposed mice over vehicle-exposed controls (data not shown). These 
results are consistent with lack of pre-fibrotic lesions in the lung 7 days after SWCNH exposure. 
No evidence for granuloma formation was observed, which is consistent with the mild and 
transient inflammatory response measured by cytokines and differential cell counts. In addition, 
there was no evidence of alveolar wall thickening or hypertrophied epithelial cells. The only 
apparent difference between SWCNH and vehicle-exposed controls was the presence of 
carbonaceous material within the cytoplasm of alveolar macrophages. Although it is possible 
that fibrosis could develop at a later point after exposure, the previous studies with SWCNTs 
reported obvious granuloma formation within 7 days post-exposure (16, 21, 24).  
Collectively, the BAL cytokine profiles and histological analysis of lung after SWCNH 
aspiration differ significantly from what has been reported for in vivo exposure to SWCNTs. Both 
Warheit et al. (2004) and Lam et al. (2004) described the presence of granulomas and 
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inflammation following intratracheal delivery of SWCNTs to rodents. In a more comprehensive 
study, Shvedova et al. (2005) performed a dose-response and time course study of SWCNT 
toxicity in mice, using particles that had been purified to remove the majority of contaminating 
iron particles. Granulomas were only found in association with dense SWCNT aggregates, but 
alveolar wall thickening was described at sites distal to aggregates, leading to the conclusion 
that even dispersed SWCNTs promoted fibrosis. In parallel, levels of TNF-α and IL-1β were 
markedly increased (up to 16-fold over vehicle-exposed levels) 24 hours post-exposure in BAL 
fluid, as were neutrophil and macrophage recruitment, followed by increased levels of the pro-
fibrotic cytokine TGF-β1 7 days post-exposure. The amounts of nanoparticles (i.e., SWCNTs) 
used in that study were comparable to those used herein, indicating that the differences in 
outcomes were not due to large differences in particle load. We also did not find evidence for 
increased oxidative stress based on the general marker of glutathione levels. A variety of 
nanoparticles have been shown to create reactive oxygen species in vitro and in vivo (4, 7). 
Specifically, SWCNTs have been shown to deplete the antioxidant glutathione (GSH) store in 
the lung with the most severe decrease occurring about 24 hours post-exposure (21). In 
contrast, we found no effects of SWCNH exposure on either total or oxidized GSH levels 24 
hours post-exposure.  
The basis for what appear to be marked differences in the potential pulmonary toxicity of 
SWCNTs and SWCNHs after in vivo exposure remains to be determined. As a relatively new 
nanomaterial, little is known about the interaction of SWCNHs with cells and with intracellular 
biochemistry. To our knowledge, only a single study has explored the response to SWCNHs, 
and it used an in vitro system (13). The authors found minimal cytoxicity associated with amino-
modified SWCNHs. There are several possible explanations for the difference in pulmonary 
toxicity of SWCNHs compared to previous studies with SWCNTs. First, although nanotubes and 
nanohorns are structurally similar, their inherent physiochemical differences could affect their 
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biological impact. These apparent toxicity differences within the general class of engineered 
carbon-based nanoparticles are not unprecedented. For example, SWCNTs show significantly 
increased cytotoxicity compared to similar amounts of multi-walled carbon nanotubes, quartz, 
and fullerene (14).  
Another contributing factor could be that  the agglomeration state of the engineered 
nanoparticles affects their toxicity (18). The agglomeration in our studies was minimized by 
using a non-ionic surfactant (Pluronic) and vigorously sonicating the material prior to aspiration. 
It is possible that coating the particles with surfactant not only facilitates material dispersion, but 
also affects their bioavailability and cellular uptake. Prior in vivo studies have relied on 
aggressive mechanical dispersion methods to maintain particle suspensions prior to delivery, 
which we combined with surfactant coating.  
A recent in vitro study reported that SWCNTs solubilized in Pluronic were readily 
phagocytosed by macrophages in a time- and temperature-dependent manner, but that uptake 
did not lead to cellular toxicity (9). On this note, we were able to easily identify particle 
aggregates within the cytoplasm of macrophages from BAL samples of mice exposed to 
Pluronic-suspended SWCNHs. In contrast, Shvedova et al. (2005) noted that RAW 264.7 
macrophages did not actively engulf SWCNTs in vitro. Further studies may be necessary to 
determine exact immunological pathways and the extent to which macrophage clearance of 
engineered carbon-based nanoparticles contributes to the net effect on pulmonary inflammation 
and pathological changes.  
Another important distinction between SWCNTs and SWCNHs is the lack (in SWCNHs) 
of metal contaminants. SWCNT production typically relies on metal catalysts that remain in final 
particle preparations, and trace amounts persist even after purification steps. In contrast, the 
SWCNHs used in this study were produced using laser ablation of pure carbon containing no 
metals. This difference in SWCNTs and SWCNHs could be an important factor in their relative 
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utility for in vivo applications, if future studies do reveal that trace metals promote secondary, 
detrimental responses to particles in vivo.  
Although we found that SWCNH-exposure resulted in an increase in the levels of several 
cytokines and chemokines in BAL fluid within 24 hours of exposure, we did not find parallel 
changes in gene expression in lung. In fact, we did not identify any genes with changes in 
expression between SWCNH and vehicle-exposed mice that were robust to statistical methods 
that controlled for multiple testing. In part this may be due to the low statistical power from a 
relatively small sample size (n=3) that is typical of microarray experiments due to their cost. In 
addition, we noted significant inter-individual variation in the expression of numerous genes, 
which would further reduce overall statistical power. The goal of the array hybridizations was to 
identify genes and pathways that were activated or repressed in the lung as part of the 
mitigation of SWCNH exposure.  
In light of the relatively modest increase in inflammatory cytokines, the lack of 
histopathological lesions, and the fact that gene expression was profiled in the whole lung 
(rather than in BAL fluid), it is perhaps not surprising that we did not observe marked alteration 
in gene expression. To our knowledge, this is the first attempt to profile the global transcriptomic 
response to engineered carbon nanoparticle exposure in vivo. The lack of detectable 
differences with SWCNH exposure will serve as a reference point for future studies of gene 
expression changes in response to other types of nanoparticles and with other experimental 
manipulations.  
In conclusion, we report that SWCNHs are a relatively innocuous agent when delivered 
to mice in vivo using aspiration as a delivery mechanism. As described above, these results are 
in contrast to those with other types of engineered carbon-based nanoparticles, raising the 
potential value of SWCNHs for in vivo applications such as drug delivery. Further study will be 
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necessary to more precisely characterize the physiochemical properties of SWCNHs and to 
define their interactions within the physiological milieu. 
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